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ABSTRACT
AN EPIDEMIOLOGICAL STUDY OF INVASIVE PNEUMOCOCCAL
DISEASE IN A SOUTH TEXAS-MEXICO BORDER
METROPOLITAN COMMUNITY
Steven Hinojosa, PhD
College of Health and Human Sciences
Northern Illinois University, 2018
Jinsook Kim, Director

This research study examines the epidemiology of invasive pneumococcal disease in
Hidalgo County, Texas. Invasive pneumococcal disease is a bacterial infection causing severe
types of clinical manifestations, including bacteremia and meningitis. Hidalgo County is the
largest metropolitan statistical area along the Texas-Mexico border. Supporting a 2016 census
population estimate of nearly 850,000, this community facilitates frequent bi-national travel,
providing unique attributes towards disease transmission. This study aims to identify if
population characteristics for infection aligned with current Advisory Committee for
Immunization Practice recommendations for vaccination against pneumococcal disease. This
includes identifying if the general healthy adult population has an increased risk for infection,
now that other populations are eligible for vaccination. Furthermore, this study aims to identify
other population characteristics at increased risk for infection, so that prevention and intervention
methods can be targeted to such groups.
Keywords: pneumococcal disease, south Texas, epidemiology, pneumococcal vaccine,
Hidalgo County, McAllen-Edinburg-Mission MSA, border health
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CHAPTER ONE: INTRODUCTION
Pneumococcal disease is a bacterial infection causing varying types of infections,
including otitis media, pneumonia, sepsis, and meningitis (Centers for Disease Contol and
Prevention [CDC], 2015a, p. 279). Pneumococcal pneumonia is the most common form of
pneumonia among adults, with an incubation period of one to three days (Wattal, Goel, &
Byotra, 2017). Pneumococcal meningitis is also the most common form of bacterial meningitis,
causing more than 50% of all types of bacterial meningitis (CDC, 2015a, p. 281). This infection
is a vaccine-preventable disease. As a bacterial infection, antibiotic therapy can be used as a part
of the treatment regimen (CDC, 2015b, p. 6). Although the introduction of vaccination has
helped decrease disease incidence, a disease burden may still exist in certain populations.
Definitions of Terms
Invasive Pneumococcal Disease (IPD): an infection of Streptococcus pneumoniae from a
normally sterile site, such as blood or cerebral spinal fluid (CSF; Gosciminski,
Bandy, & Luther, 2017, p. 57)
PCV13: pneumococcal conjugate vaccine, 13 valent
PPSV23: pneumococcal polysaccharide vaccine, 23 valent
Bacteremia: the presence of bacteria within the blood
Meningitis: an inflammation of the meninges (i.e., brain and spinal cord membranes)
Otitis Media: middle ear infection
Trypanophobia: the fear of needles
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Socioeconomic Status: a combined measure, typically incorporating economic, social,
and work status (Adler & Stewart, 2010)
CDC: Centers for Disease Control and Prevention
ACIP: Advisory Committee on Immunization Practices
MSA: metropolitan statistical area
Case: an episode of infection
Significance of the Problem
Prior to the introduction of the PCV7 vaccine in 2000, pneumococcal disease was a
leading cause of disease morbidity and mortality in the United States. Within the United States,
approximately 400,000 hospitalizations occur each year due to pneumococcal pneumonia (CDC,
2015a, p. 281). This also includes an estimated 3,000 cases of meningitis and 50,000 cases of
bacteremia each year (Gosciminski et al., 2017, p. 57). Additionally, it has been documented that
certain populations, such as pediatric and geriatric age groups, have presented concerns for
increased risk of infection (Nhantumbo et al., 2016).
In children, Streptococcus pneumoniae is the leading cause for otitis media, pneumonia,
sepsis, and meningitis. Each year, an estimated 1.6 million children under the age of five die due
to pneumococcal-related illnesses worldwide (Nhantumbo et al., 2016, p. 2). With other bacterial
infections decreasing in incidence in the pediatric population, pneumococcal disease is now the
most common type of infection in children under five in the United States. Additionally, an
estimated five million cases of otitis media occur each year in children under five years old, with
at least 60% of the population having at least one episode of this infection by the age of 12
months (Centers for Disease Control and Prevention, 2015a, p. 281).
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Infection for adults can be just as serious. Each year, approximately 600,000 to 800,000
adults die due to pneumococcal pneumonia, sepsis, and meningitis worldwide (Muley, Ghadage,
Yadav, & Bhore, 2017, p. 31). More specifically, 20% of adult cases of pneumococcal meningitis
result in death, increasing to 50% in developing countries (Muley et al., 2017, p. 31). During the
year 2004, pneumococcal disease was accountable for over 22,000 deaths in the United States,
and over 4 million episodes of disease (Song et al., 2013, p. 1). Furthermore, when examining
invasive pneumococcal disease (IPD), the Centers for Disease Control and Prevention (CDC)
estimates 2,400 cases of mortality due to bacteremia and an additional 1,200 cases due to
meningitis to occur annually within the United States (CDC, 2015a, pp. 281-282).
Antibiotic therapy regimens can be used to treat patients with pneumococcal disease,
especially those with invasive infections. However, research has shown that some antibiotics are
no longer effective due to resistance from the pathogen (Muley et al., 2017; Nhantumbo et al.,
2016; Stacevičienė et al., 2016). Therefore, vaccination becomes more important as prevention
treatment options may become more limited in the future.
Finally, pneumococcal disease not only presents a health impact but also an economic
one as well. Invasive pneumococcal disease (IPD) presents an economic burden estimated at a
cost of $3.5 billion in 2004 for direct medical costs in the United States (Song et al., 2013, p. 1).
This creates an economic burden for the patient as well. Within a 970-patient, multicenter
hospital-based study, the median cost for direct medical care was $7,452 per patient (Song et al.,
2013, p. 3).
Research Topic
This research study will explored the epidemiology of invasive pneumococcal disease
(IPD) in a south Texas metropolitan area using an ecological study design. It incorporated
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statistical and geographical analyses to identify which populations are at most risk for infection.
Variables include age, infection type, hospitalization, vaccination status, and other clinical and
socioeconomic factors. Specifically, this study aims to identify if current ACIP pneumococcal
vaccine recommendations are adequately protecting the general adult healthy population and
whether further research is needed to amend current recommendations to protect a broader
population.
The study’s community is defined as Hidalgo County, Texas. This is also the McAllenEdinburg-Mission metropolitan area, which represents all jurisdictions and populations located
within the county lines of Hidalgo County, Texas (U.S. Census Bureau, 2017).
Hidalgo County Population
Hidalgo County is a Texas county located along the United States-Mexico border in the
southern tip of Texas. The county as a whole also represents the McAllen-Edinburg-Mission
metropolitan statistical area (MSA). The United States Census Bureau estimates the 2016
population size of this community as 849,843 (U.S. Census Bureau, 2017). The McAllenEdinburg-Mission MSA is the largest MSA along the US-Mexico border and fifth largest in
Texas. Hidalgo County is made up of 22 cities, 27 zip codes (26 complete and 1 partial), and 113
census tracts (U.S. Census Bureau, 2016). These 22 cities within the county, along with their
populations are listed in Table 1.
The population of Hidalgo County is relatively young, with a median age of 28.8 years.
The county’s residents are predominant Hispanic or Latino (91.8%), followed by White
alone/not Hispanic (6.6%), Asian alone (1.1%), and African American (0.8%). Between 2011 and
2015, the percentage of foreign-born persons was estimated at 28.8%. In terms of socioeconomic
representation from 2012 to 2016, the median household income was $36,094. The per capita
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income for the last 12 months of the period between 2011 and 2015 was $14,689. Over a third
(34.2%) lived under the poverty line. Additionally, nearly a third (32.0%) of those under the age
of 65 years did not have health insurance (U.S. Census Bureau, 2016). Nearly a quarter of the
population (22.8%) had less than a 9th-grade education. The overall educational proportion of
those graduating high school or higher was 63.3%, but increased to 77.1% in the 25-to-34 yearold population (U.S. Census Bureau, 2016). The median household size for owner-owned
properties (non-rentals) was 3.70 in Hidalgo County compared to 2.70 for the United States (U.S.
Census Bureau, 2016). Finally, the 2010 population per square mile was 493.2, and the total
geographical land area of the county is 1570.87 square miles (U.S. Census Bureau, 2017).
Table 1: Hidalgo County Cities and their Populations
City

2016 Population

Alamo
Alton
Donna
Edcouch
Edinburg
Elsa
Granjeno
Hidalgo
La Joya
La Villa
McAllen
Mercedes
Mission
Palmhurst
Palmview
Penitas
Pharr
Progreso
Progreso Lakes
San Juan
Sullivan City
Weslaco

19,679
17,278
16,638
3,365
90,280
7,134
301
13,931
4,286
2,740
142,696
16,734
84,424
2,738
5,792
4,886
79,487
5,938
248
36,981
4,153
40,358
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Purpose of Study
The primary objective of this research is to examine the disease burden and population
characteristics for infection of invasive pneumococcal disease. This includes examining which
age groups are most susceptible to infection and which populations are at increased risk for
severe complications. Secondary objectives include examining and comparing subpopulations to
determine if socioeconomic factors contribute to disease morbidity and other outcomes.
Geographical techniques were employed to determine potential correlation of disease alongside
income and population density. Additionally, current literature is limited in regards to the
epidemiology of pneumococcal disease within United States-Mexico border communities. Since
the literature has shown different characteristics of disease between the two countries in regards
to serotype, infection type, morbidity and mortality (Sherchan et al., 2015; Song et al., 2013; van
der Linden, Falkenhorst, Perniciaro, Fitzner, & Imöhl, 2016), this study will provide insight into
disease outcomes where a population is influenced by two countries. Furthermore, this research
will contribute information and outcomes that have not previously been established and assist in
identifying if disease incidence and infection characteristics differ from national representation.
Study Justification
Research has shown that the introduction of the pneumococcal vaccine has decreased the
incidence of the disease (Askim et al., 2016; Gosciminski et al., 2017). However, with current
vaccination recommendations, those who do not qualify under these recommendations are still at
risk for infection, resulting in disease morbidity and even the possibility of death. Therefore, the
question arises whether there is adequate herd immunity protecting those ineligible for
vaccination or if this is a susceptible population currently unprotected. Additionally, by

7

conducting research on those already infected, targeted populations can be identified for future
public health interventions.
Pneumococcal vaccination has decreased incidence in pediatric and geriatric populations
(Gosciminski et al., 2017). This study’s aim focuses on the general adult healthy population,
establishing risk for this disease within this population segment. It is currently unclear if this
population has significant risk for disease. It is also unclear if this issue stems from lack of
vaccination or a lack of eligibility for vaccination. Therefore, this study examined if those cases
infected in the general adult population should have been vaccinated or if they did not qualify, as
per Advisory Committee Immunization Practices (ACIP) recommendations.
Within the epidemiological literature, there has been little focus on border populations.
Few studies have examined invasive pneumococcal disease in Latin and southern America, with
even fewer studies in focusing on Mexico. With bi-national transit allowing various infectious
diseases to transmit across borders, it is vital that increased research takes place in these border
regions so that clearer transmission risks are identified. Furthermore, infection types can vary
globally, and with a bi-national population it is vital to understand whether national vaccination
recommendations are protecting such communities. Additionally, this population represents a
much lower income representation as compared to communities in other studies. Therefore,
studying this population provides contextual opportunities when exploring socioeconomic status
and its role in disease outcomes for pneumococcal disease.
Currently, the literature presents a strong representation of pediatric populations globally,
especially those groups under the age of five years (Hsiao et al., 2015; Sherchan et al., 2015).
Additionally, the current literature has reviewed geriatric populations and those with
comorbidities currently covered under ACIP recommendations (Marcus et al., 2016; Wattal et al.,
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2017). However, studies examining the adult population are less abundant. This is especially true
when studying the healthy adult population, where no comorbidities or conditions constitute
vaccine recommendations. Therefore, this study will assist in contributing to a research focus of
the adult population where little to no research currently exists.
Theoretical Frameworks and Models Overview
Theoretical frameworks and models for this study encompass concepts of disease
transmission and population health. The epidemiologic triad represents a model of disease
causation (Centers for Disease Control and Prevention [CDC], 2012). The triangle of human
ecology depicts the health status of the individual and the influence of external factors (Meade &
Emch, 2010, p. 30). Herd immunity defines the threshold for population immunity (Hendrix,
Sturm, Zimet, & Meslin, 2016). The Health Disparities framework examines health inequity
among social groups (Adler & Stewart, 2010). The socioecological model of health depicts the
influences that can be placed on a person’s health (Ferrer, Trotter, Hickman, & Audrey, 2014, pp.
3-4). Finally, the willingness-to-pay concept examines the patient and healthcare cost
relationships (Prosser et al., 2004, pp. 283-284). The frameworks and models presented are
illustrated in the appendices.
Research Questions
This research brings forth questions on infection of invasive pneumococcal disease and
its relationship to a susceptible population.


With vaccination recommendations established for pediatric, geriatric, and high-risk
populations, is the healthy general adult population still at high (or increased) risk for
infection?
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Within this study population, do high-risk patients experience a longer hospitalization
duration and higher risk of mortality?



Does socioeconomic status, such as household income, influence the rate of disease
within the study population?
Limitations
This epidemiological study of invasive pneumococcal disease had some limitations. The

study was a longitudinal and ecological study, spanning from 2010 to 2016. Although this study
design does provide extended annual data, it creates cross points in patient data. This means that
once a patient is discharged from a hospital, their ultimate recovery and outcome are unknown. It
is also unknown if they returned to a hospital due to complications, unless the patient tests
positive for pneumococcal disease again. Furthermore, with additional and cheaper healthcare
access options just south of the border, those seeking medical care in Mexico will likely not be
reported to the Hidalgo County Health and Human Services Department. It is Texas state law to
report this disease, but this law is not applicable in Mexico. Therefore, cases may be missed for
those identified in Mexico.
Since this is not a cohort study, little to no information will be known after hospital
discharge. Information was limited to only during the initial medical visit or hospitalization. This
type of case investigation does not routinely involve patient contact or follow-up. Therefore,
long-term patient outcomes, such as post-discharge survival and person-time, were collected.
Some variables of interest were not complete or available, such as vaccination history.
Texas has a state-wide immunization registry. However, this is an opt-in program, meaning that
patients must choose to signup, rather than automatically being enrolled. Adult patients are less
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likely to be in this registry as compared to pediatric patients. Additionally, patients who are poor
historians of their vaccination history or lack a medical home may have missing information for
vaccination status. Patients may also mistake the pneumococcal vaccine for other vaccines, such
as the influenza or TDaP (tetanus, diphtheria, and acellular pertussis) vaccines. Furthermore,
since it is suspected that most cases of disease will present to a hospital at time of diagnosis,
many of these facilities may not have the vaccine history on record, as compared to primary care
providers.
This research study focused on those who had a positive infection for pneumococcal
disease. Therefore, as compared to a case-control study, there is no data reflecting individuals
protected from disease. Examples include populations who were already vaccinated or not
vaccinated but successfully were not infected at the time of study. These populations could have
provided further information on population characteristics, positive and negative, for infection
versus protection.
Summary of the Study
A vaccine has been developed for pneumococcal disease, creating an opportunity to
prevent disease. This includes preventing more severe clinical manifestations of disease, such as
sepsis and meningitis. However, even with the introduction of vaccine options, pneumococcal
disease is still a risk for certain populations, potentially including those who do not qualify under
national recommendations. Therefore, the theoretical frameworks described in this chapter
identify the foundational platforms that depict and exemplify the significance of this problem.
With the multifaceted presence of this health issue, this ecological study addressed the
relationship of disease, impact of at-risk populations, and identified the interaction of
explanatory and response variables. Additionally, with disease characteristics varying globally,
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limited research has been conducted among communities in Latin American, Mexico, and along
the United States-Mexico border. Furthermore, this epidemiological study assessed a south Texas
border community and its characteristics for risk of infection from invasive pneumococcal
disease. This study will identified those populations most susceptible for infection and those age
or risk groups that may be susceptible to more severe disease outcomes. This study also
examined whether it is indeed an issue of risk of infection among the general adult population or
if those considered high risk are not receiving protection from disease due to undervaccination of
eligible patients. In addition, socioeconomic factors, such as income were assessed to determine
if they have any influence on disease risk. Geographical analysis assisted in identifying
population characteristics associated with higher rates of infection. Furthermore, this study
assessed the disease outcomes to determine areas of concern so that public health intervention
and prevention methods can be identified.

CHAPTER TWO: LITERATURE REVIEW
Pneumococcal disease’s cause is the pathogen Streptococcus pneumoniae. This pathogen
is a lancet-shaped bacterium that normally forms as diplococci or less commonly can be single or
in chains (Centers for Disease Control and Prevention, 2015a, p. 279). Pneumococcal disease can
take place in different forms of infections, this including otitis media, pneumonia, sepsis, and
meningitis (CDC, 2015a, p. 280).
Streptococcus pneumoniae was first discovered by Louis Pasteur in 1881 from the saliva
of a patient with rabies. By 1940, more than 40 serotypes of the bacteria had been identified
(CDC, 2015a, p. 279). The prevalence of the organism Streptococcus pneumoniae is estimated to
be present in about 10% of the general population. This can then be transmitted to others, leading
to infection. If the bacterium passes beyond the epithelial cells, it can then lead to invasive
disease (Askim et al., 2016, p. 2). Currently, a total of over 92 serotypes have been identified,
which are classified based on their type-specific antisera (CDC, 2015a, p. 279).
Pneumococcal pneumonia, a clinical syndrome of pneumococcal disease, has an
estimated incubation period of one to three days. Symptoms can include fever, cough, chest pain,
tachypnea, hypoxia, malaise, and weakness (CDC, 2015a). Pneumococcal pneumonia represents
over a third (36%) of adult-acquired pneumonia. About 25-30% of those with pneumococcal
pneumonia develop pneumococcal bacteremia (CDC, 2015a, p. 280). Pneumococcal bacteremia
is defined as a bacterial presence within the blood. This type of infection can be without focus
and cause general febrile illness (Azzari et al., 2015a, p. 2). Each year in the United States over
12,000 cases of pneumococcal bacteremia occur. Additionally, the case fatality rate is estimated

13

at 20% in the general population and as high as 60% within the geriatric population (CDC,
2015a, p. 278). Another type of infection from pneumococcal disease is pneumococcal
meningitis. With 3,000 to 6,000 cases annually, this type of infection is the most common type of
bacterial meningitis in the United States, accounting for over 50% of infections. Symptoms can
include headache, lethargy, vomiting, irritability, fever, nuchal rigidity, cranial nerve signs,
seizures and coma (CDC, 2015a, pp. 279-282).
Literature of Theoretical Frameworks and Models
The following are existing theoretical frameworks that describe components that are
linked to this study. These include concepts of disease transmission and population health. These
components also support a holistic model, the socioecologic pyramid of human disease, which
describes the relationships and influences of this study. First, the epidemiologic triad represents a
model of disease causation (Centers for Disease Control and Prevention [CDC], 2012). This
model depicts a triangle, with each vertex representing a factor in disease transmission. This
includes the host, the agent, and the environment. The host represents the patient or individual
susceptible to infection. The agent is the pathogen causing disease, such as the Streptococcus
pneumoniae bacterium leading to pneumococcal disease. The environment depicts extrinsic
factors that influence disease transmission. This can include physical factors, such as geology
and climate, or socioeconomic factors, like crowding and poor sanitation (Centers for Disease
Control and Prevention, 2012). The epidemiological triad presents the overall relationship of
communicable diseases. This framework depicts the foundation of how Streptococcus
pneumoniae spreads person to person, potentially manifesting as pneumococcal disease.
Furthermore, it provides a foundation for epidemiologic research for identifying risk factors
important in public health prevention and intervention.
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A similar framework is the triangle of human ecology. Central to this model is the health
status of the individual or population under study and how it is influenced by the categories of
habitat, population characteristics, and behavior (Meade & Emch, 2010, p. 30). These three
categories form the vertices of the triangle. The first vertex, habitat, encompasses the home,
neighborhoods, schools, healthcare facilities, workplace, or built environment, such as roads.
Next, the population vertex includes age, genetics, immunity, and nutritional status. The third
vertex is behavior. Behavior is defined as the observable acts in a cultural context. This includes
economic constrains, social norms, education, political, technological, and other influences
(Meade & Emch, 2010, pp. 30-31).
Another theoretical model is herd immunity. Herd immunity refers to a theory that once a
threshold is met within the population, others who are not vaccinated may potentially have a
reduced risk and ultimately protection against infection (Hendrix et al., 2016). These thresholds
represent community protection of vaccine-preventable diseases, where a certain percentage of
the population vaccinated can prevent future clusters and outbreaks. This theory can be
formulated in vaccine-preventable diseases, including invasive pneumococcal disease (IPD).
Along with herd immunity, the basic reproduction number (R0) plays a role as well. The basic
reproduction number refers to the average number of susceptible people who become infected
(Hendrix et al., 2016). This number predicts the scale of a disease during an outbreak, usually set
to be either above or below one (1). With increased vaccination, the susceptible population
decreases and so does the R0 (Hendrix et al., 2016). This model presents the importance of
research in both the epidemiology and vaccination of pneumococcal disease. Specifically, within
this study, vaccine and epidemiological research is supported using this model. This includes
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examining disease incidence and determining whether ACIP recommendations for the
pneumococcal vaccines are supporting herd immunity protection within the adult population.
The health disparities framework is defined as health inequity among social groups
(Adler & Stewart, 2010). This framework examines how the health of certain populations can be
poorer when compared to others due to their race/ethnicity, income, education, and other
characteristics. When examining this border community, health inequity may be of concern due
to overall social standing and access to care when compared to other communities. Hidalgo
County has lower socioeconomic status as measured by median household income, health
insurance coverage, and education completion rates when compared to Texas and the United
States (U.S. Census Bureau, 2017).
The socioecological model of health, as presented in Appendix A, depicts the influences
that can be placed on a person’s health. This model shows the various layers of influences
towards an individual’s health, including individual, interpersonal, organizational, community,
and public policy (Ferrer et al., 2014, pp. 3-4). The individual level represents how individual
patients influence their own health. At the interpersonal level, health is impacted by the patient’s
family members, friends, and healthcare providers. The organizational level begins incorporating
health insurance providers and health departments, offering access to care. The community level
encompasses media, community-based organizations, and employers. Both the organizational
and community levels represent an important influence for public health education on disease
prevention. The public policy level represents the policies and laws, such as with federal vaccine
recommendations (Ferrer et al., 2014, p. 3). As a whole, this model categorizes the important
influences for determining data variables to be collected in this research study.
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Economics and financial factors are also important to be examined when exploring
frameworks for this research study. The concept of “willingness to pay” is defined as the
theoretical amount a patient will pay for an intervention to prevent a negative health outcome
(Prosser et al., 2004, pp. 283-284). Within this willingness-to-pay study for the pneumococcal
vaccine, economic modeling was developed to identify such trends as vaccine costs while
incorporating medical and non-medical event outcomes (Prosser et al., 2004). Examples include
vaccination cost to prevent episodes of specific infection (i.e., otitis media or pneumonia) or
even a timed series (i.e., three days of illness or quality-adjusted life years). In regards to this
focus of research, the pneumococcal vaccine is an available prevention tool. However, with the
lower median household income of this population, it is of interest whether infected patients
qualified for vaccination and if cost could be a potential barrier.
Epidemiology of Invasive Pneumococcal Disease
Morbidity and Mortality
Prior to the year 2000, invasive pneumococcal disease was a leading cause of disease
morbidity and mortality (Gosciminski et al., 2017, p. 57). However, even in the present day, IPD
presents high disease morbidity and mortality globally (Hsiao et al., 2015, p. 1). In many
countries, although a vaccine-preventable disease, pneumococcal disease is still a leading cause
of childhood deaths (Sherchan et al., 2015, p. 47). Furthermore, in developed countries, overall
mortality rate is estimated at 20% but increases to as high 50% in developing countries (Muley et
al., 2017, p. 31).
A regional study in Sweden (Backhaus et al., 2016) examined the epidemiological
characteristics of invasive pneumococcal infections. A total 2,977 cases were included from 1996
to 2008. Descriptive statistics were performed to identify population characteristics, including

17

age, gender, and comorbidity presence. The mean age was 60.6, and the median age was 65
years. Men made up 1,483 cases, and women made up 1,494 cases. Of all cases, 1,994 (67%) had
at least one comorbidity, and only 67 (2.25%) cases had a documented history of vaccination,
mostly from the PPSV23 vaccine (Backhaus et al., 2016, pp. 3-6).
In another study (Askim et al., 2016) the Charlson Comorbidity Index (CCI) was used to
examine risk of infection. The CCI combines both age and comorbidities to represent a
numerical risk value. Within this study, a total of 414 patients with pneumococcal sepsis were
reviewed. Of these, 144 (34.8%) patients had a CCI score of zero, 190 (45.9%) has a score of 12, and 80 (19.3%) had a score 3 or greater (Askim et al., 2016, p. 4). Comorbidity infections
were also examined individually, with 98 hypertension patients (23.7%) and 96 chronic
obstructive pulmonary disease (COPD) patients (23.2%) as the most common conditions (Askim
et al., 2016, pp. 4-5).
High-Risk Populations
The Centers for Disease Control and Prevention (CDC) and the Advisory Committee on
Immunization Practices (ACIP) have identified certain population characteristics as high risk for
infection of pneumococcal disease. For age groups two years and older, this includes chronic
illness, anatomic or functional asplenia, immunocompromised conditions, HIV infection,
cochlear implants, or cerebral spinal fluid (CSF) leak. Additionally, those 19 years and older who
smoke cigarettes or have asthma are also considered high risk for infection (CDC, 2015a, pp.
289-292).
A healthcare system study in the United States (Marcus et al., 2016) compared risk of
infection between HIV-infected (n=13,079) and uninfected (n=137,643) individuals. Incidence of
disease was compared among these two groups from 305 cases per 100,000 person-years in 1996
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to 88 cases per 100,000 person-years in 2011. HIV-infected individuals had a significantly higher
risk for infection (p<0.001) during all time periods, with decreasing ratios as years progressed. In
1996-1999, HIV-infected individuals had an adjusted risk ratio of 18.5, as compared to
uninfected individuals. More recently, in 2010 to 2011, HIV-infected individuals had an adjusted
risk ratio of 6.6, as compared to uninfected individuals, presenting findings that pneumococcal
vaccination among the HIV-infected population helped decrease the incidence rates of IPD
(Marcus et al., 2016, pp. 465-467).
Diabetes is another risk factor for pneumococcal disease. In a United States medical
claims study (Weycker et al., 2016) diabetes mellitus was the most common chronic condition
among at-risk patients (18-64 years), representing 43% of the 13,368,935 claims. Additionally,
patients with diabetes had an overall incidence rate ratio (IRR) of 4.3 (Weycker et al., 2016, p.
4). Another study (Fay, Hoppe, Schulkin, & Eckert, 2016) surveyed obstetrics and gynecology
residents to assess their knowledge on pneumococcal vaccination indications for pregnant
patients. A total of 238 respondents were included within the survey. In regards to pneumococcal
vaccine indications, only 35.8% of respondents successfully identified diabetes as an indication
for vaccination (Fay et al., 2016, p. 3).
Population Characteristics
Pneumococcal disease epidemiology presents population characteristics, such as age and
other risk factors. A Norwegian observational study (Askim et al., 2016) examined the
epidemiological outcomes of adults with septic pneumococcal disease. Within the 1993-2011
dataset, the mean age was 67 years old, with 48.3% aged 69 or younger (Askim et al., 2016, pp.
3-4). A study in Sweden (Backhaus et al., 2016) examined the epidemiology of invasive
pneumococcal infections. Between 1996 and 2008, a total of 1,083 cases were identified, with
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485 cases aged 18-64 years and 530 cases aged 65 or greater (Backhaus et al., 2016, p. 7). In a
South Korean retrospective cohort study, data from ten university hospitals were collected on
invasive pneumococcal disease (IPD). A total of 970 patients were identified with IPD, and of
these, the 50-64 age group was most common (33.0%), with a median age of 60.9 years (Song et
al., 2013, pp. 6-7).
Border Health and Latin American Populations
Current literature presents limited epidemiological information on those populations in
Latin America, Mexico, or along the United States-Mexico border. These regions may include
populations that have different characteristics when compared to other populations across the
nation. Furthermore, with these transient Latin American populations, disease risks and attributes
may meld with United States-Mexico border communities.
A study in Mexico City (Gómez-Barreto, Espinosa-Monteros, López-Enríquez, JiménezRojas, & Rodríguez-Suárez, 2010) assessed the epidemiology and mortality risks factors of
invasive pneumococcal disease in a pediatric hospital. A total of 156 patients were included in
this study, with hospitalizations from 1997 to 2004. Of these patients, 69.3% had at least one
underlying condition (Gómez-Barreto et al., 2010, p. 393). The overall mortality rate of these
patients was 27.5%, and of those cases, 81.4% had at least one underlying condition. Bacteremia
and meningitis have an odds ratio of 2.3 for mortality risk, as compared to other types of
infections (Gómez-Barreto et al., 2010, p. 395).
A study in Guatemala (Contreras et al., 2015) examined the 2008-2012 incidence of
pneumococcal pneumonia in 188 hospitalized adults. In this study, that most common age group
affected was those aged 65 and older (38%), with an incidence rate of 31.3 per 100,000
(Contreras et al., 2015, p. 10). The most common symptoms presented included cough (92%),
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difficulty breathing (84%), and reported fever (72%). Of all patients, 65% had consolidation or a
large effusion identified on chest x-rays (Contreras et al., 2015, p. 4). With data representing
adult cases 2008-2012, the study presented a baseline prior to the 2013 vaccine introduction in
children (Contreras et al., 2015).
An August 2014 Morbidity and Mortality Weekly Report (MMWR; Nyangoma et al.,
2014) assessed respiratory infections of unaccompanied minors traveling to the United States
from Central America. In the 2014 report, clusters of pneumococcal disease were identified in
both California and Texas. A total of six cases, aged 14-17 years old, were identified. All six
cases were identified as serotype 5 (Nyangoma et al., 2014, p. 698).
The research articles presented above describe the limited literature currently available on
Latin American and United States-Mexico border communities. Therefore, this presents the need
for additional research examining these communities to identify if similar disease characteristics
occur or if instead novel public health interventions will need to be developed to better combat
invasive pneumococcal disease in these areas.
Spatial Epidemiology
Limited research is currently available on the spatial epidemiology of pneumococcal
disease. However, the available literature does present research on spatial analysis methods in
regards to other diseases. In one spatial epidemiology study (Stopka et al., 2017) hotspots, an
area of elevated disease burden, of hepatitis C in Massachusetts was characterized. In that study,
spatial analysis techniques included counts and incidence rates per census tract, kernel density,
and hotspot maps (Stopka et al., 2017, p. 5). The study also presented methods for data cleaning,
such as correcting mismatched zip codes, and geocoding to obtain longitude and latitude
coordinates (Stopka et al., 2017, p. 3). Another study (Jeffery, Ozonoff, & Pagano, 2014) focused
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on spatial aggregation to map risk of disease. In that study, leukemia data in New York were
analyzed using a non-parametric distance-based mapping (DBM) approach (Jeffery et al., 2014,
p. 2). The method used disease point data, placed onto grids, to create high-risk areas.
A study in southern Ethiopia (Tadesse, Enqueselassie, & Hagos, 2018) examined the
spatial epidemiology of tuberculosis. In that study, global spatial autocorrelation was conducted
to examine clustering of cases. Moran’s index was compared on an annual basis to identify
patterns, resulting in significant clustering each year (Tadesse et al., 2018, pp. 6-10). A study on
avian influenza in Zhejiang Province, China (Wu et al., 2017) also incorporated spatial
autocorrelation to examine five waves of Avian Influenza epidemics. In that technique, Moran’s
index was also used for local analysis, where high-low and low-high autocorrelations were
examined (Wu et al., 2017, p. 3).
In a Netherlands dietary study (Dekker, Rijnks, Strijker, & Navis, 2017) the Getis Gi hot
and cold spot analysis tool was utilized to study snack patterns. In consideration of
pneumococcal disease, these spatial analysis techniques support methods for identifying
additional risk factors and disease trends. Examples of this include geocoding point data into
polygon symbology to compare disease incidence rates and through conduction spatial statistical
analysis to identify if any significant risk factors are present regarding toward infection.
Vaccination
Research has shown that pneumococcal disease can be prevented through vaccination
(Chih-Cheng, Sheng-Hsiang, Chun-Hsing, Wang-Huei, & Po-Ren, 2014; Gosciminski et al.,
2017). There are two main types of vaccines overall to protect against diseases: live-attenuated
and inactivated. A live attenuated vaccine refers to when the vaccine contains a diseaseproducing wild-type pathogen (i.e., bacteria or virus). This pathogen can then replicate within the
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body to produce immunity without causing illness. Some examples of live-attenuated vaccines
include the mumps-measles-rubella-varicella (MMRV) vaccine and the nasal influenza vaccine
(CDC, 2015b, pp. 4-6). Inactivated vaccines refer to those that contain pathogens that have been
killed. This is accomplished through techniques using heat and chemicals. These vaccines do not
cause disease from an active infection, creating the need for a multidose series as immunity
wanes over time (CDC, 2015b, pp. 5-6).
Pneumococcal Vaccination
In the National Health and Wellness Survey (NHWS), from 2007 to 2011, adult
vaccination was assessed. For pneumococcal disease, a total of 43.8 million adults had received
at least one vaccine, representing 19.2% of adults (Annunziata, Rak, Del Buono, DiBonaventura,
& Krishnarajah, 2012, p. 5). Pneumococcal vaccination rates were also assessed in another
United States surveillance study (Williams et al., 2016). In the 2014 study, pneumococcal
vaccination coverage in high-risk adults, aged 19-64 years, was 20.3%. In adults 65 years and
older, vaccination rates were 61.3%. In the 19-64 age group, Caucasians had the highest rate of
vaccination at 21.1%, second was African Americans (20.2%), third was Hispanics (16.4%), and
fourth was Asians (14.6%; Williams et al., 2016, pp. 4-5). In a 2011-2015 pediatric study in the
United States (Hill, Elam-Evans, Yankey, Singleton, & Dietz, 2016), pneumococcal vaccination
rates among infants 19-35 months old were examined. For a three-dose series coverage,
vaccination rates ranged from 92.3% (2012) to 93.6% (2011). For a four-dose series coverage,
this rate ranged from 81.9% (2012) to 84.4% (2011; Hill et al., 2016, p. 1066).
The pneumococcal vaccine belongs to the category of polysaccharide vaccines. These are
inactivated vaccines, composed of long sugar molecule chains with a surface capsule of the
pathogen. The two types of polysaccharide vaccines for pneumococcal disease include pure and
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conjugate (CDC, 2015b, pp. 6-7). Once inoculated, antibody development for the protection of
disease usually occurs within two to three weeks (CDC, 2015a, p. 286).
The pure version is called the pneumococcal polysaccharide vaccine (PPSV). The first
PPSV was licensed in 1977 as a 14-valent vaccine, protecting against 14 serotypes of bacteria. In
1983, the PPSV23, protecting against 23 serotypes, replaced the previous 14-valent version,
which can still be used currently. This version of the vaccine contains 25 mcg of each antigen per
dose and 0.25% phenol as a preservative (CDC, 2015a, p. 284). Some areas of concern are
present with pure polysaccharide vaccines. First, pure polysaccharide vaccines are not
consistently immunogenic in children under two years of age. This may be because of
immaturity in their immune systems. Second, a booster vaccine does not evoke an increased
response for immunity, inhibiting long-term protection against disease (CDC, 2015b, pp. 6-7).
The pneumococcal conjugate vaccine (PCV) is a vaccine that undergoes conjugation.
This process chemically combines the polysaccharide to the antigen, resulting in immunogenic
response in infants and through antibody boosters (CDC, 2015b, p. 7). The first pneumococcal
conjugate vaccine was licensed as a 7-valent vaccine in the year 2000. In 2010, the 13-valent
vaccine was introduced in the United States. In 2012, ACIP recommendations for the PCV13
were for immunocompromised adults aged 19 years and older and in 2014 for all adults aged 65
years and older. One 0.5mL does of PCV13 contains 2.2µg of polysaccharide of 12 of the
serotypes and 4.4µg of polysaccharide for serotype 6B. The 13 serotypes within this conjugate
vaccine include 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, and 23F (CDC, 2015a, pp. 284-285).
Current ACIP vaccine recommendations for the general pediatric population include a
four-dose series at 2, 4, 6, and 12-15 months of age of the pneumococcal conjugate vaccine
(PCV) (CDC, 2015a, p. 287). In unvaccinated adolescents aged 6 to 18 years, a single PCV dose
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is recommended if a high-risk condition is present (i.e., anatomic asplenia,
immunocompromising conditions, cochlear implant, or cerebrospinal fluid leak). For patients 65
years and older, a single dose of PCV is recommended, followed by a single dose of PPSV 6-12
months after the initial dose. If the PPSV was the initial dose, an additional single dose of PCV is
recommended no sooner than 12 months after the initial PPSV dose. For high-risk adults aged
19-64 years old, an initial dose of PCV is recommended, followed by a dose PPSV eight weeks
later (CDC, 2015a, pp. 288-289).
Serotype Studies
Serotype studies can be beneficial in identifying specific infections that are circulating
within a population (or community). This is also helpful in targeting certain geographic areas,
based on their serotype presence among infections. Globally, serotypes can vary based on the
region where infection is occurring. With this information, preventive methods such as
vaccination and vaccine research can be implemented. This includes identifying if the most
prevalent serotypes are matched to currently available pneumococcal vaccines and identifying if
certain serotypes cause more severe infections. In a study within a Taiwanese hospital (Hsiao et
al., 2015), the epidemiology of infection by serotype was conducted to determine clinical
features and outcomes. Among meningitis patients, the following serotypes were identified: 19F
(3 cases), 6B (1 case), 15 (1 case), 19A (1 case), 23F (1 case), and unknown (3 cases).
Pneumonia patients had the following serotypes: 19A (19 cases), 14 (5 cases), 6B (2 cases), 6A
(1 case), 23F (1 case), non-typeable (1 case), and unknown (8 cases; Hsiao et al., 2015, p. 88).
By categorizing infection type by serotype, the study was able to determine if certain serotypes
are prone to causing more severe infections.
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Specifically, regarding acute bacterial meningitis, a study in Mozambique (Nhantumbo et
al., 2016) examined the serotype distribution of children with invasive pneumococcal disease. In
the study, a total of 352 samples were collected. Of these samples, 119 were isolated with S.
pneumoniae. Of these samples, 50 met criteria to be serotyped. Of the 50 samples, 17 were not
typeable through the study’s detection methods. The following serotypes were identified: 9V (12
cases), 1 (6 cases), 5 (5 cases), 14 (4 cases), 4 (3 cases), 6A (3 cases), 23F (3 cases), and 6B (2
cases). Serotypes 12, 15B, and 3 each had one case (Nhantumbo et al., 2016, pp. 4-5). By
focusing on this population within a specific geographical area, the researchers were able to
identify the most prevalent serotypes to cause acute bacterial meningitis within the study’s
parameters. In addition, both of these studies present an example of how serotypes can differ
based on geographic region, population, and infection type.
Vaccination Barriers, Hesitancy, and Acceptance
Even with a vaccine currently available, barriers still exist against vaccination. Without
adequate protection, patients, especially those considered high risk, are susceptible to infection
as well as complications from the disease. Trypanophobia refers to the fear of needles, and this
fear can lead to health consequences and implications, such as vaccine refusal (Taddio et al.,
2012). This type of fear has been documented to impede vaccination efforts among both children
and adults (Taddio et al., 2012, p. 4807). In a Canadian survey (Taddio et al., 2012), over 1,900
parents and children were asked about vaccination at a local museum. Of these respondents, 24%
of parents and 63% of children reported at least some form of trypanophobia. Additionally,
among those surveyed, 7% of adult and 8% of children immunizations resulted in noncompliance (Taddio et al., 2012, p. 4807). Studies like this can be used to focus on areas of
concern and where interventions can be developed. One example is in the age groups presenting
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trypanophobia within the Canadian study. The 4-8 age group presented the highest rate of fear,
encompassing 56% presenting with fear within that particular age group (Taddio et al., 2012, p.
4809).
Vaccination hesitancy and acceptance have been described in the literature to be
attributed to multiple factors (Ferrer et al., 2014; How How, Phua See Chun, Shafi, & Jakes,
2016; Prosser et al., 2004). Within a research article on vaccine hesitancy (MacDonald, 2015),
the 3 C’s model is presented. This model focuses on the concept of vaccine acceptance and
hesitancy. This vaccine hesitancy model encompasses behaviors contributing to the decisionmaking process of vaccines. Vaccination hesitancy refers to either a delay in acceptance or
refusal of vaccination and can be the result of different influences. In correspondence, vaccine
acceptance is a behavior that stems from a complex decision-making process that encompasses
many factors (MacDonald, 2015, p. 4162). These determinants can be represented through
models and matrices to depict the influences on the vaccine decision-making process.
As presented in Appendix B, the 3 C’s model represents three core areas: complacency,
confidence, and convenience. Complacency refers to not getting vaccinated due to the perceived
risk of getting infected. Influential factors of complacency can include life and health
responsibilities, where other responsibilities are regarded as more important at that point in time
of decision. Another component of complacency is self-efficacy, which refers to the selfperception of ability to actually get vaccinated (MacDonald, 2015, p. 4163). Confidence refers to
the trust in a vaccine. More specifically, this is divided into three key segments. First, trust in
effectiveness and safety of the vaccine. Second, trust in system delivery (i.e., health services and
health professionals). Third, trust in the policymakers who passed regulations on the need of the
vaccine. Vaccine convenience refers to the accessibility of the vaccine. This includes physical
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availability, affordability and willingness to pay, geographical accessibility, and health literacy of
uptake for the vaccine (MacDonald, 2015, pp. 4162-4163). The 3 C’s model represents the
potential barriers to vaccination, such as with the pneumococcal vaccine. In addition, it supports
this work of research within pneumococcal vaccination and disease epidemiology because it
presents the factors associated with vaccination and the factors within the decision-making
process. As this study explores vaccination history, explanatory variables, such as census tract
income, will help identify whether socioeconomic influences play a role in vaccination coverage
within the community.
Treatment and Antibiotic Resistance
Pneumococcal disease, like other bacterial infections, can be treatable with antibiotic
therapy (CDC, 2015a). This is utilized through the incorporation of an antibiotic treatment
regimen in patients. However, antibiotic resistance can greatly limit the treatment options for
pneumococcal disease. Studies within the literature have been conducted to determine if any
antibiotic resistance is present that could compromise treatment plans and regimens for patients.
Antibiotic resistance is determined through antimicrobial susceptibility panels. These
profiles are developed through culturing and isolating the bacteria and then testing the bacteria
against a series of antibiotics. When testing bacterial resistance to antibiotics, two main
categories are developed: susceptible and non-susceptible. Susceptible refers to bacteria that are
sensitive, displaying no resistance to a particular antibiotic. Non-susceptible refers to bacteria
either being intermediate or fully resistant to an antibiotic (Stacevičienė et al., 2016). Within the
antimicrobial susceptibility panel, each antibiotic is given a numerical value, known as the
minimum inhibitory concentration (MIC). MIC refers to the lowest concentration of an
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antimicrobial needed to limit bacterial growth (Muley et al., 2017, p. 32). The scores are then
categorized into susceptible, intermediate, or resistant.
Geographically, antimicrobial susceptibility profiles can range greatly. The literature has
shown that non-susceptibility to Penicillin for S. pneumoniae can range from as low as 1.7% in
Norway to as high as 83% in Romania. Additionally, non-susceptibility to Erythromycin can
range from 1.2% in the Czech Republic to up to 65.5% in Italy (Stacevičienė et al., 2016, p. 2).
The discrepancies in antimicrobial profiles depict how disease management may need to be
different for each population affected.
An observational study in a tertiary care hospital in India (Muley, Ghadage, Yadav, &
Bhore, 2017) examined patients with invasive infections admitted to one facility. A total of 120
patients with suspected invasive infections were included within the study. Of these patients, 55
patients had S. pneumoniae isolated. The following antimicrobial susceptibility patterns were
identified: 22/55 isolates were resistant to Cotrimoxazole, 7/55 resistant to Chloramphenicol,
4/55 resistant to Ciprofloxacin, 2/55 resistant to Erythromycin, and 0/55 resistant to Cefotaxime.
No more than two antibiotics were resistant within a single isolate (Muley et al., 2017, pp. 3234).
An antimicrobial study in Nepal (Sherchan et al., 2015) examined the susceptibility
patterns of S. pneumoniae isolates from children with clinical meningitis. A total of 24 isolates
were tested for antimicrobial susceptibility. Penicillin, Cefotaxime, Chloramphenicol, and
Erythromycin were sensitive to almost all isolates (23 out of 24). More specifically, both
Penicillin and Cefotaxime each had 23 samples sensitive, 1 sample intermediate, and 0 samples
resistant. Cotrimoxazole had 15 samples sensitive, 4 samples intermediate, and 5 samples
resistant. Both Chloramphenicol and Erythromycin each had 23 samples sensitive, 0 samples
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intermediate, and 1 sample resistant (Sherchan et al., 2015, pp. 48-59). Cotrimoxazole shows an
increased occurrence of resistance, as compared to other antibiotics, creating potential concerns
in usage of this antibiotic over others as a part of the treatment regimen.
In Lithuania (Stacevičienė et al., 2016), a similar study was conducted examining S.
pneumoniae isolates and their resistance patterns. A total of 367 isolates were included within the
study. The majority of isolates (56.7%) were sensitive to all antibiotics tested. Overall, of all
samples, 15.8% were non-susceptible to Penicillin, 21.3% to Erythromycin, 16.9% to
Clindamycin, and 27.3% to Trimethoprim–Sulphamethoxazole. All isolates were susceptible to
Norfloxacin and Vancomycin. In addition, 67.9-82.4% of non-susceptible isolates were those
found in pneumococcal conjugate vaccines (Stacevičienė et al., 2016, pp. 4-6). This finding
depicts how vaccination can help reduce the prevalence of pneumococcal serotypes exhibiting
antimicrobial resistance.
A Mozambique study (Nhantumbo et al., 2016) presented higher rates of resistance as
compared to the previous studies. A total of 17 isolates were profiled with susceptibility panels.
Of these, 15 were resistant to Penicillin, 11 resistant to Tetracycline, 6 resistant to
Chloramphenicol, 4 resistant to Erythromycin, and 2 resistant to Vancomycin. None of the
isolates were resistant to Ceftriaxone. However, all of the 17 isolates were resistant to
Trimethoprim-Sulfamethoxazole (SXT; Nhantumbo et al., 2016, pp. 5-7). With increased
resistance, vaccination is an important preventative tool, since treatment options are becoming
more limited within this population.
Policy and Economics
The Advisory Committee for Immunization Practice (ACIP) sets forth the national
recommendations for vaccination (Black et al., 2017). This includes utilizing current research to
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determine which populations should receive which vaccines, at what age, and how many doses
(Annunziata, Rak, Del Buono, DiBonaventura, & Krishnarajah, 2012, p. 1). These decisions
reflect not only who is recommended to receive vaccination but also which claims will be
reimbursed when submitted through insurance, such as with Medicaid and Medicare (Black et
al., 2017, p. 728).
A cost analysis study (Weycker et al., 2016) examined the rates and financial outcomes of
pneumococcal disease from three healthcare claims repositories. Within the study, invasive
pneumococcal disease (IPD) and pneumonia medical costs were compared among healthy, atrisk, and high-risk patients. In the study, healthy was defined as the absence of comorbidities or
risk factors. At risk was defined as immuno-competent with one or more chronic medical
conditions. High risk was defined as those who were immune-compromised, immunesuppressed, or had a cochlear implant (Weycker et al., 2016, p. 2). Overall, patients considered at
risk or high risk resulted in 3 to 43 times higher healthcare costs per 100,000 person-years. In the
18-64 age group, the difference in the annual cost of pneumonia increased from the healthy
group of $1.8 million per 100,000 persons to $13.9 million per 100,000 persons for the at-risk
group and to $50.4 million per 100,000 persons for the high-risk group (Weycker et al., 2016).
This observed increase in costs can be considered to be multifactorial, due to increased disease
incidence, in-patient care costs, and hospitalization duration.
In a multicenter hospital study in South Korea, the mean direct medical costs per case
was $7,542 ,which was not significantly different between age groups (Song et al., 2013, pp. 34). Hospitalization duration was greatest (22.0 days +/-16.5) in the 18-49 year high-risk group
and lowest (15.3 days +/-15.7) in the 18-49 years moderate-risk group (Song et al., 2013, pp. 5-
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6). Overall, clinical disease burden increased with age, but medical costs associated with
infection had no significant variation among the age-risk groups.
In a Colombian economic study (Ordóñez & Orozco, 2015), the preventive costs for the
pneumococcal vaccination was assessed. In that study, a comparison was made between the costs
of different types of pneumococcal vaccines and their projected medical costs averted.
Vaccinating 90% of the pediatric population with the PCV10 would result in a cost of
$28,920,564 but would result in an excess savings of $13,703,271 in medical costs. Additionally,
vaccinating 90% of the pediatric population with the PCV13 would cost more, at $31,904,432,
but would result in an even greater cost avoidance of $19,479,395 (Ordóñez & Orozco, 2015, p.
6).
A Chinese study (Caldwell, Roberts, An, Chieh, & Bruce, 2015) focused on the economic
impact of pneumococcal vaccination during an annual influenza epidemic as well as an influenza
pandemic. Within that study, modeling was predicted in terms of routine pneumococcal
vaccination of infants. If routine vaccination were to occur in the population, over 75,000 deaths
could be prevented from secondary pneumococcal pneumonia during an annual year of epidemic
influenza. This number increases to over 700,000 deaths during an influenza pandemic, resulting
in an estimated $6.3 billion in avoided cost (Caldwell et al., 2015, pp. 8-9). The study
recommended the integration of the pneumococcal vaccine for routine childhood vaccination in
China to help reduce healthcare costs during influenza seasons and pandemics.
Willingness to Pay
In a study examining willingness to pay (WTP) for the pneumococcal conjugate vaccine
(Prosser et al., 2004), adults’ values in disease prevention associated with pneumococcal
infection were measured. A series of questions were asked through an algorithm-styled interview,

32

where vaccine cost and disease outcome questions were based on previous answers. Overall,
adults responded with a median WTP of $100 to prevent one episode of otitis media, $400 to
prevent one severe episode of pneumonia, and upwards of a median of $500 to reduce the risk of
meningitis. The overall median WTP for parent participants was $250 and $300 for community
participants (Prosser et al., 2004, pp. 284-288).
Another concern of vaccination coverage is accessibility through insurance coverage and
income. In an adult vaccination study in the United States (Annunziata et al., 2012), the National
Health and Wellness Survey (NHWS) was used to identify vaccination coverage. The odds ratio
for receiving the pneumococcal vaccine was 1.783 for those who possess health insurance.
Additionally, income was compared within the study. Income was categorized into three levels:
<$25k, $25-50k, and >$50k. Overall, a slight general trend showed decreased vaccination rates
among those in lower income levels. For pneumococcal disease, the vaccination odds ratio per
income level were <$25k (OR=0.992), $25-50k (OR=1.14), and >$50k (OR=1.144; Annunziata
et al., 2012, p. 7).
Conceptual Framework Diagram
The pre-existing frameworks and literature presented here describe a foundational
platform for this research study. Furthermore, they help transcribe the development of a model
reflective of these themes. Appendix C depicts the socioecologic pyramid of disease. This model
depicts an evolutionary theoretical framework, incorporating the previous foundational models
mentioned and expanding them to describe the research study of interest. The human (or patient)
is at the top, with internal factors making up the middle tier and external factors forming the base
tier. This structure presents how external factors can affect middle-tier factors resulting in overall
risk of disease for the individual. At the base level, larger scaled factors are presented. These
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include population, physical environment, and healthcare policy and economics. These factors
present external factors that can affect disease of the individual. Socioeconomic status and access
to care are just above the base level, where they have both community and individual level
influence. Next is behavior towards vaccination, where this factor is determined by the
individual patient. This includes making health-related decisions that affect the overall health of
the individual. Finally, towards the top of the pyramid, just below the human, is pathogenesis.
This refers to both the organism and act of disease transmission. All these factors are interrelated
and the inputs of each factor affect the outcome of disease within the individual.
Finally, there is the conceptual framework diagram, Appendix D, which presents the
relationship of variables. This encompasses variables both included and excluded from this
research study. This diagram is divided into five areas: patient risk factors, lower socioeconomic
status, increased human disease transmission, pathogenies, and disease outcomes. The first four
core areas defines the input variables while the fifth core area (disease outcomes) define the
output variables. Those variables shaded in green present the variables included within this study.
The variables shaded in yellow represent those variables identified within the literature but are
not a part of this study due to this information is not routinely collected within epidemiological
disease investigations.
The first core area is patient risk factors. In this core area, age and comorbidities are
variables of interest within this study. This then includes vaccine history, which can be affected
by the patient’s eligibility based on age or comorbidities. Not included within this study is
trypanophobia, the fear of needles or vaccination. This variable has an impact on vaccine history
as well. Finally, in this core area gender and occupation are included as well. Occupation
information was not available for this study and therefore was not included in the study.
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The second core area is socioeconomic status. Since individual socioeconomic data are
not available for case patients, population-level data are represented at the census tract level. The
two variables for this core area include median household income and private health insurance
coverage. These two variables will be proxies for socioeconomic status and its relationship to
disease incidence and risk.
The third core area is human disease transmission. This core area encompasses the
variables that can influence the human-to-human transmission model. More specifically, this
core area looks at median household size and population density at the census tract level to
determine whether this is an increased risk for disease.
The fourth core area is pathogenesis. In this core area, the factors related to the
pathogenicity of the disease are examined. This includes infection type, serotype, and antibiotic
resistance. These three variables affect the patient prevention and intervention methods for
infection. Only infection type was included within this study because serotype and antibiotic
resistance information was not be available from the abstracted dataset.
Finally, the last core area is disease outcomes. This core area is different than the first
four core areas because it is dependent (as a variable or variables) on the risk factors or
independent variables. Variables in this core area include hospitalization duration and mortality,
which indicate the morbidity and severity of infection from the disease.
Conclusion
The literature review explored the different areas of pneumococcal disease. This included
examining the epidemiology of disease, where morbidity and mortality, high-risk populations,
and other population characteristics were reviewed. Additionally, border health and Latin
American studies were identified and presented. However, this also identified that there is
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limited literature that focuses on these specific populations. Literature in spatial epidemiology
was reviewed, depicting the different analysis techniques for geographical disease analysis. The
area of prevention and treatment was also incorporated, encompassing vaccination and
antimicrobial susceptibility. Policy and economic literature presented barriers and areas of
consideration for disease prevention and transmission. Finally, a theoretical framework and a
conceptual framework diagram were developed, incorporating these common themes, to describe
the research study of interest.

CHAPTER THREE: METHODS AND DESIGN
To complete this research, a retrospective cross-sectional study was developed to assess
the epidemiology of invasive pneumococcal disease in Hidalgo County, Texas. As a quantitative
cross-sectional study, the same data variables were collected and analyzed for the duration of the
identified time frame. Data were primarily analyzed statistically as single-grouped data as a longterm cross-sectional dataset. However, annual case trends were compared with one another in a
longitudinal format. Data were analyzed from the years 2010 to 2016. This range in years was
selected based on potential external influences, such as vaccine introduction. Therefore, this
range limits potential population infection shifts, as compared to including prior years of data.
This seven-year dataset was selected to provide information on infection post-2010 PCV13
vaccine introduction, as well as current case counts and details. These data reflected only
infected cases, as compared to a case-control study that would examine both populations.
Furthermore, with a vaccine now available as prevention, this study examined future populations
that need to be targeted for public health interventions.
Research Questions
The literature review presented findings of disease epidemiology and outcomes leading to
several research questions. First, with vaccination recommendations established for pediatric,
geriatric, and high-risk populations, is the healthy general adult population still at high risk for
infection? This is of novel interest since the literature has shown decreased incidence within the
pediatric, geriatric, and high-risk groups based on their respective vaccination recommendations.
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This leads to the question of whether there is a different population at increased risk that does not
currently fall under ACIP vaccine recommendations.
Another question is whether infection type and comorbidities affect final outcomes. Final
outcomes can include hospitalization duration and deceased indicator. Therefore, within this
population of study, do high-risk patients experience a longer hospitalization duration and higher
risk of mortality? With concerns such as diabetes and obesity in this population it is a question
whether this can contribute to more severe outcomes from infection.
A third question focuses on population characteristics and infection. This includes
examining population-based socioeconomic attributes and comparing them to disease rates. This
includes determining whether certain socioeconomic status contributes to risk for infection
within this population. Therefore, does socioeconomic status, such as income, influence the rate
of disease in a population? Identifying these socioeconomic risk factors can help determine if
additional specific interventions need to be addressed. Furthermore, identifying these risk groups
for infection can help determine if health equity is present within the community.
Hypotheses
The first research question examined age groups and incidence of infection. Therefore,
this epidemiological study assisted in identifying disease trends within each group. This included
defining the adult population as vaccine ineligible (vi) and the pediatric, geriatric, and high-risk
populations as vaccine eligible (ve). In addition, this question then presented the following null
and alternative hypotheses. H0: The vaccine-ineligible adult population (18-64 years) has no
significant difference in the probability of pneumococcal disease, as compared to vaccineeligible populations (H0: pvi < pve). H1: The vaccine-ineligible adult population (18-64 years) has
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a significant difference in the probability of pneumococcal disease, as compared to the vaccineeligible populations (H1: pvi ≥ pve).
The second research question compared risk factors to hospitalization duration and
recovery status. The literature has presented the notion that the higher risk and older populations
correlate to longer hospital stays and increased risk of mortality. Therefore, the following
hypotheses are stated. H0: There is no significant difference in hospitalization duration for
pneumococcal disease between the age-risk groups identified (H0: µPedi = µHA = µHRA = µGeri).
H1: There is a significant difference in hospitalization duration for pneumococcal disease
between the age-risk groups identified (H0: µPedi ≠ µHA ≠ µHRA ≠ µGeri).
The third research question explored socioeconomic status and the risk factors for
infection. The literature has shown lower income populations to have lower vaccination rates and
higher infections. Therefore, the following hypothesis tested if this is true for the population of
study. H0: Within the population of study, lower income populations have no increased risk in the
rate of infection for invasive pneumococcal disease (H0: Β1 = 0). H1: Within the population of
study, lower income populations have an increase risk in the rate of infection for invasive
pneumococcal disease (H1: B1 ≠ 0).
Pre-Data Collection
This research study followed and complied with appropriate protocols and procedures
necessary to conduct such research. This included establishing a memorandum of understanding
for data exchange and submitting for institutional review board (IRB) approval.
The Office of Research Compliance, Integrity and Safety at Northern Illinois University
was contacted prior to data collection and analysis. A screening application was submitted for
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IRB review and approval. On May 7, 2018, the Office of Research Compliance, Integrity and
Safety determined that this research study does not meet the definition for human subject
research and was accepted to continue with this study (Protocol # HS18-0133). To ensure that
this research study abides by the Health Insurance Portability and Accountability Act of 1996
(HIPAA), no identifiable data was collected, and no individuals were contacted. Instead, only deidentified medical information was collected, reviewed, and analyzed for the purposes of this
research project.
Data and Information Exchange
Data reflected previously collected information as a part of routine epidemiological
investigation of public health. Data and information, for the development of this research, were
exchanged through collaboration with the Hidalgo County Health and Human Services
Department, located in Edinburg, Texas. A memorandum of understanding (MOU) was presented
and approved at Hidalgo County Commissioners Court on Tuesday, September 12, 2017. This
memorandum allows for the exchange of public health information and data with Northern
Illinois University for the purposes of research and prevention of notifiable conditions. Both
parties, Northern Illinois University and Hidalgo County, Texas, have agreed upon its terms and
information exchange, and this MOU is active until December 2020.
Data Collection
Data collection took place through the exchange of information with Hidalgo County,
Texas. Hidalgo County Health and Human Services Department (HCHHSD) provided
epidemiological case information on pneumococcal disease and associated laboratory result data
for analysis. In addition, supportive information and data were referenced from the United States
Census Bureau for population and geographic analysis.
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The information from Hidalgo County, Texas, reflected data extracted from the National
Electronic Disease Surveillance System (NEDSS). This is a public health information system for
data entry and electronic information exchange of notifiable conditions (Center for Surveillance,
2017). This is a national system used by all fifty states where public health workers investigate
cases of notifiable diseases, such as invasive pneumococcal disease, and enter this information
into the system (Center for Surveillance, 2017).
The data from Hidalgo County was exported using the surveillance system, NEDSS. This
occurred by running the Bacterial Meningitis Invasive/Respiratory Disease Report (BMIRD) in
NEDSS while incorporating certain parameters. The time parameter was defined as January 1,
2010, to December 31, 2016, defined by collection date. Within the query, the following
parameters were set: Jurisdiction equaled Hidalgo County Health and Human Services
Department, Morbidity and Mortality Weekly Report (MMWR) year was equal to or greater
than 2010 and equal to or less than 2016. Case status was not equal to not a case, so that all
types of cases were included (i.e., confirmed and probable). Next, variable selection included
demographical and clinical information. No patient-identifying variables were included within
the report. Finally, the report was exported as a comma space value (.csv) file.
The American Fact Finder, from the U.S. Census Bureau, was used to access the
American Community Survey (ACS) data. A total of five datasets were extracted from this data
source. To retrieve economic data, search queries were enacted within the American Fact Finder
for median income for Hidalgo County, Texas. Once identified, the table builder was specified to
include census tracts, and a .csv file was created and downloaded. Population and demographic
data were also retrieved. From this file, data was cleaned up by pulling only necessary variables,
such as the median and mean household income, tied to their appropriate census tract. The first
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dataset extracted was the Median Household Income in the Past 12 Months (2016) ACS report.
The second dataset extracted was the Health Insurance Coverage by Type (2012-2016) ACS
report. The third dataset extracted was the Educational Attainment (2012-2016) ACS report. The
fourth dataset extracted was the Hispanic or Latino Origin (2012-2016) ACS report. The final
dataset extracted was the Place of Birth for the Foreign-Born Population in the United States
(2012-2016) ACS report. A final query was built for population size, so that an incidence rate
could later on be calculated. A raw .csv file was downloaded, and data cleanup was also needed
for this dataset. The census tract identification codes were transposed into actual census tract
numbers through multiple steps of deleting and adjusting prefixes and suffixes. Once completed,
all data components were compiled into a single Excel spreadsheet for future analysis.
Population
Data was collected from the Hidalgo County Health and Human Services Department,
under a memorandum of understanding for data exchange. This included epidemiological data of
invasive pneumococcal disease from 2010 to 2016, to reflect a seven-year timespan. This data
was reflected as cases, defined as patients or clients who were reported to the local health
department with an identified laboratory culture of Streptococcus pneumoniae from a normally
sterile site (i.e., blood or cerebrospinal fluid).
Residency was defined as living within Hidalgo County, Texas, at time of specimen
collection date. Citizenship status did not affect residency. Therefore, all patients were included
within the data analysis as long as the identified case had a Hidalgo County physical or PO box
address represented within the medical record data. This included special populations, such as
winter Texans and undocumented individuals, who have defined residency within Hidalgo
County. The term “winter Texans” refers to individuals from the Northeast, Midwest, amd
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Pacific Northwest of the United States or Canada who migrate to Texas during the winter (Rio
Grande Valley TX, 2018). However, patients who were under United States Customs and Border
Patrol custody at time of specimen collection were considered out of area and excluded as
Hidalgo County residents for this study. This is because their identified exposure likely occurred
prior to arriving to the United States and would incorrectly contribute data for analysis of this
local population and community.
Case Definition
All cases were determined and defined by the Texas Department of State Health Services’
Epidemiology Case Criteria Guide in regards to case status of invasive pneumococcal disease.
This included clinical compatibility and the presence of an identified culture for S. pneumoniae
from a normally sterile site. Appendix F provides an example of the 2017 Texas DSHS case
definition for Streptococcus pneumoniae invasive disease (IPD). The case determinations are
made through an epidemiological investigation to collection data and information of the
infection. Appendix G presents the Texas DSHS case investigation form for streptococcal
disease, including invasive pneumococcal disease. Appendix G shows which type of information
are collected during a case investigation for this notifiable condition. Patients who have had
more than one infection were included once, for their first infection meeting case definition.
Methods in Data Cleanup
The data was first received from Hidalgo County Health and Human Services as a
raw .csv file, containing the whole requested dataset. Therefore, this required the necessary steps
involved with data cleanup to make this data applicable to this research study.
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Data Quality
For the first step in data cleanup, the .csv file of the epidemiology dataset was first
converted and saved to an Excel spreadsheet to allow for edits and changes to be saved. Next,
each variable was reviewed for completeness and accuracy. Variables that did not contain any
entries were deleted and excluded for the purposes of this study. This included information that is
not routinely collected within the standard epidemiological investigation. Examples of these
variables included daycare history, other vaccine histories (i.e., meningococcal and Haemophilus
influenza type b), and medical insurance. Next, variables needed for data analysis were reviewed
for completeness. Any variables with a data entry completion rate greater than 98% were allowed
to stand as is. Variables with less than 98% were reviewed to determine subsequent steps. The
primary variables of interest where this threshold was not met was hospital discharge date and its
related variable, hospitalization duration. To assist in rectifying this missing data issue, patterns
of missing data were assessed to determine if any trends existed in the missing data. In the
comment section of many of the cases with missing discharge dates, it was noted that the patient
was still admitted into the hospital at the time of the investigation being completed. Therefore,
those patients who had prolonged hospitalization durations were at risk for being mispresented in
the data. A retrospective review of the data was requested from Hidalgo County to include these
missing dates.
All data variables and their content were reviewed to ensure adequate data quality. Data
quality began with examining variable completion. This included examining demographical and
clinical variables of interest for this study, such as age, gender, zip code, city, ethnicity, and
hospitalization status. Additionally, duplicate entries were reviewed and subsequent results were
deleted. This was done to ensure that if a patient was infected and reported multiple times, their
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data would not construe any outcomes. Data was verified with Hidalgo County Health and
Human Services Department to ensure accuracy and completeness. When information was
identified to be missing, a request was sent to Hidalgo County, as allowed within the
memorandum of understanding. For data with minimal missing fields, data analysis was run
normally, while excluding those rows with missing fields. Variables with notable missing values
were reassessed to determine the actions of such data analysis.
Another technique in data cleanup was cross-referencing of case investigations and
laboratory results. Lab accession IDs were cross-referenced to verify specimen site and infection
type. This included verifying that all identified clinical meningitis cases derived from
cerebrospinal fluid (CSF) specimen sources.
Data Variables
Data variables were used for numerical and categorical classification. Identification keys
were created with no linkage or connection to original patient identification numbers. All patient
identification and case numbers were excluded. Variables of interest included both explanatory
and response variables. Explanatory variables of interest included, AdultGeri, Age Category,
AgeCatName, Age Reported, Concentrated Race, CurrentSexBinary, EthnicityBinary, Hospital
ID, Infection Type, Underlying Conditions, Vaccination History, Vaccine Eligible, and Risk
Group. For the spatial analysis among the census tracts, variables of interest included Median
Household Income, Private Health Insurance Coverage, Household Size, Educational
Attainment, Hispanic Representation, Foreign-Born Representation and Population Density.
Response variables included Hospitalization Status, Hospitalization Duration, and Deceased
Indicator. Hospitalization Duration was a continuous variable while Deceased Indicator was a
dichotomous variable. A case fatality rate (CFR) was calculated, stratified by age groups.
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Comorbidities and risk factors were assessed for those who may be eligible for pneumococcal
vaccination but were identified to have no current vaccinated status.
Demographic Data
The following demographic data was extracted for data analysis: age, gender, census
tract, city, ethnicity, and race. Gender was a dichotomous variable for both male and female. Age
was represented in its numerical value and was also translated into a categorical variable,
AgeCatName, to compare pediatrics, adults, and geriatrics. The age category variable,
AgCatName, supported representing vaccination recommendation age groups, such as pediatric
and geriatric, compared to non-recommendation age groups. Demographic variables for this
study include:


Age



Age Category



Sex



Census Tract



City



Ethnicity



Race



Population Density



Household Size



Household Income



Educational Attainment



Foreign-Born

Ethnic and race data was collected and reviewed as well. Overall data was likely
expected to produce minimal outcomes, due to the high single-ethnicity (Hispanic)
representation in the county. However, ethnicity and race data was compared among age groups
to determine if a higher rate of Caucasian cases occur in the geriatric group. This is because a
large winter Texan population is present within the county and helped identify if this special
population presented an overall higher incidence of rate in proportion to other resident
populations.
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Census tract data was used to identify pockets of incidence and disease burden. This data
was also paired with US Census data to integrate socialeconomic analysis. All geographical data
that was collected and analyzed abided by the Health Insurance Portability and Accountability
Act (HIPAA).
Clinical Data
Clinical data variables included Facility/Hospital Location, Hospitalized vs Outpatient,
Hospitalization Duration, Infection Type, Deceased Indicator, Vaccine History, Comorbidities,
and Symptom Onset. Hospitals were renamed and assigned an ID, such as Hospital 1, Hospital
2, etc, to protect their identifiable information within this study. Infection types were divided to
include meningitis, bacteremia, and other as their categories. Comorbidities were included
individually and also grouped as equal to or greater than one for the creation of a high-risk
variable. This high-risk variable was based on risk factors defined by ACIP vaccine
recommendations. The variables of study include:


Facility Location



Hospitalization



Hospitalization Duration



Infection Type



Deceased Indicator



Vaccine History



Comorbidities



Symptom Onset



Risk Group

Descriptive statistics were conducted to determine the in-patient versus out-patient
frequency for case infections. In-patient settings were defined as including any hospitalization
stay with an admission. This definition included both same-day discharge and extended stays.
Visits to the emergency department were defined as out-patient visits. Hospitalization duration
was also assessed. Hospitalization duration was examined in correlation to explanatory variables
of interest. This included hospital facility and age-risk group (i.e., pediatric, health adult, high-

47

risk adult, and geriatric). Age-risk groups included identifying and representing comorbidity
presence as a high-risk adult category (i.e., immunocompromised-conditions, diabetes, and
chronic conditions). Hospitalization duration was also be compared among hospital facilities to
determine if any hospital has a significant difference is duration, as compared to others.
Vaccination history was assessed to determine the following objectives. First, to identify
if adequate data is available to identify vaccine history in patients. This was completed, since it
was suspected that many patients were hospitalized and that their primary care provider
information was unavailable. Therefore, if the patient was not in the state immunizations registry,
his or her vaccination status for pneumococcal disease would likely be unknown. Second, for
those who were eligible for vaccination, their history can be examined to determine if they
received the recommended vaccinations.
Age-risk groups were categorized as well, based on comorbidities and risk factors. This
included healthy and high-risk. As mentioned earlier, the four groups included pediatric, healthy
adult, high-risk adult, and geriatric. Healthy adult was defined as patients (18-64 years) who do
not currently fall under any recommendations for pneumococcal vaccination. High-risk adult was
defined as patients (18-64 years) with at least one factor or condition identified as a risk factor
indication for pneumococcal vaccination, excluding age. A high risk variable, HighRisk, was
established based on the presence of one or more high-risk comorbidities in a patient, as defined
by ACIP vaccine indications. This was created as a dichotomous variable, where 1 represented
high-risk and 0 represented healthy (no risks identified). A separate variable, VaccineEligible,
was also created as a dichotomous variable (0=no, 1= yes) to represent all factors, both
comorbidities and age, of vaccine eligibility.
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Mortality was assessed based on associated explanatory variables. This included analyzed
comorbidities to determine their effect on deceased indicator. More specifically, the abundance
and type of comorbidities were examined to identify areas of higher risk for mortality. Mortality
was compared between hospitals to identify if significant proportions or risk ratios are present,
based on hospital facility.
Reporting Data
Reporting measures were also examined to determine if private provider and public
health investigation are taking place in a timely manner. As per Texas Department of State
Health Services and Texas Administrative Code, notifiable diseases must be reported to the local
health department within a designated time frame. This is to ensure adequate response and
intervention time by public health staff. Invasive pneumococcal disease must be reported to a
local health department within seven days of an identified case by a private provider (Texas
Department of State Health Services, 2017). Once reported, the local health department has thirty
days to complete the investigation and submit it to the state health department. Both these
numerical timeline measures were evaluated to determine if timeliness is taking place for proper
public health surveillance and intervention.
Data Analysis and Software
Data analysis took place with Stata (v14.2 StataCorp), Excel, and ArcGIS (v10.6). These
three forms of software supported statistical analysis, data visualization, and geographical
analysis. This data analysis also tested the three hypotheses of this research study, as well as
other supportive analyses. Although QGIS software provided a strong platform for case and
incidence mapping, once statistical and spatial analysis was needed, this software did not provide
full capability. This included conducting ordinary least squares (OLS) and geographic weighted
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regression (GWR). Therefore, a student license of ArcGIS was procured to more efficiently
handle these spatial analysis techniques.
Data was first graphically examined to determine if normal distribution is present. Visual
data included box plots that were created to identify the range, quartiles, and median. This also
helped visualize the spread of the data. Specifically, this was completed for variables such as age
and hospitalization duration. Other data visualization methods included performing quantilequantile plots to determine if the data is normal. Histograms were created as well. Histograms
were created to visually compare gender incidence, age, and overall annual disease incidence.
Longitudinal comparisons were made, based on annual case trends and subgroups within these
annual trend analyses.
Statistical Analysis
Descriptive statistics were performed to present the population of study. The annual case
counts were depicted in a histogram to show case trends. Then a table was created to depict
disease case representation by sex, age, ethnicity, underlying conditions, hospitalization duration,
deceased status, and infection. To further examine case representation, box plots were created for
annual age distribution. Cases were also examined as seasonal trends to identify which months
had a greater case occurrence over the seven-year period. Different statistical analysis techniques
were used to identify the population of study and to test the hypotheses previously addressed. In
this study, three hypotheses were of focus and tested to examine vaccination history,
hospitalization, and population characteristics. These hypotheses were also supported through
additional analysis techniques, such as post hoc and spatial analysis.
Data analysis for this research study also focused on the three presented hypotheses. This
included calculating coefficients and odds ratios (ORs) to analyze which characteristics
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presented the greatest risks for infection. This was completed to compare age categories, risk
groups, hospital facility, and vaccine eligibility. Additionally, stratified analysis took place to
identify if any effect modification or confounding bias exists. This included conducting
stratification among demographical characteristics and comparing these variables among the
overall coefficients and odds ratios. Furthermore, census population data was incorporated as
well to assess and identify population-level risk factors for infection. This included utilizing
demographical and socioeconomic data to assess disease incidence.
1st Hypothesis Methods: Vaccine Eligibility in Cases
Initial statistical analysis focused on the first hypothesis of this study. This hypothesis is
concerned with the case occurrence of vaccine eligibility among the age-risk groups of the
population within this study. To begin, descriptive statistics were created, focusing on the
demographics identified. A table was created to summarize the overall case representation of
infections. This included presenting case counts by age group (i.e., pediatric, adult, and geriatric)
and then depicting case breakdowns by sex, ethnicity, and infection type.
To support this hypothesis, the variable Age was assessed as both numerical and
categorical variables. To further assess the numerical age values, an age categorical variable was
created to allow for further analysis. The pediatric group included cases under the age of 18, the
adult group included ages 18 to 64, and the geriatric group included 65 years and older. The
variable AgeCatName represented a string name for the three categories, which was then
transcribed into the following numerical categories: pediatric (1), adult (2), and geriatric (3) for
the variable AgeCategory.
All 329 cases were assigned a vaccine eligibility status. This was accomplished by
reviewing medical risk factors in the case data entry, the age, and other social risk factors that
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determined ACIP and CDC vaccine indications. To determine vaccine eligibility and indication,
descriptive statistics were reviewed for the proportion of cases that met vaccine eligibly based on
the age or risk factors. A variable for vaccine eligibility was created as a dichotomous variable.
This included a value of 1 for “yes” and a value of 0 for “no” in regards to a vaccine indication
for the pneumococcal vaccine. Eight of the cases were identified as having disease exposure
prior to two months of age, making them ineligible for vaccination. Therefore, these eight cases
were excluded from this portion of the analysis to not misrepresent disease risk in the vaccineeligible pediatric population. A 2x2 chi-square cross-tabulation association table was created to
compare the frequency of vaccine history and vaccine eligibility. This cross-tabulation was
created to help identify if these primary cases of disease could have been preventable through
vaccination, if a vaccinated population was still infected, or if the population did meet
vaccination indications. Next, binary logistic models were run to assess hospitalization and
deceased status. Patients were categorized into a dichotomous variable on whether or not they
had at least one comorbidity that was considered high risk for infection. Then binary logistic
regression were run for both hospitalization status and deceased indicator to determine if there
was any increased risk for either based on comorbidity presence.
To test the first hypothesis, a binomial probability test was performed upon certain
parameters. First, the binomial test examined the adult versus geriatric age groups to identify if
there was any significant difference between the two groups. This analysis looked specifically at
age and did not compare comorbidities or other health risk factors. Next, a binomial probability
test was also performed to determine if there was no significant difference in case probability
between the vaccine-indicated population and the vaccine-ineligible population. Finally, a post
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hoc binomial test was examined specifically for the 18-64 age group. The case occurrence was
compared between the vaccine-eligible and vaccine-ineligible groups.
2nd Hypothesis Methods: Hospitalization Duration in Risk Groups
The second hypothesis is concerned with disease outcomes by age and risk of infection.
Before testing the 2nd hypothesis, descriptive statistics were conducted to identify the attributes
of hospitalization and mortality. Whisker-box plots were created to compare the groups of study
interest (i.e., pediatric, adult, high-risk adult, and geriatric) in terms of hospitalization duration
(in days). Other data visualizations included box plots of overall hospitalization duration by
hospital facility. As with the 1st hypothesis, the numerical age and hospitalization duration
continuous variables were assessed to determine if these variables were normally distributed. In
this hypothesis, hospitalization status, hospitalization duration, and mortality were the three
outcome variables of interest.
First, hospitalization status was assessed. This was defined as being admitted into a
hospital facility. Emergency departments without admission were not considered as hospitalized.
Descriptive statistics were preformed to define the age-risk groups that were hospitalized. Then,
a chi-square test of association was performed to compare hospitalization rates of these groups.
Next, binary logistic regression was then performed to assess hospitalization status among highrisk versus generally healthy groups. A binary logistic regression model was also conducted to
assess age and sex.
After hospitalization status was analyzed, hospitalization duration was examined next.
The count, range, and average was calculated of overall hospitalization durations, as defined in
days. As mentioned earlier, a box plot was created to identify the duration of each hospital
facility. To assess normality of the data, a Shapiro-Wilk test was run. Linear regression was
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conducted to compare the numerical age and lengths of hospitalization duration. Additional
analysis included conducting a one-way ANOVA for age categories and hospitalization duration.
This one-way ANOVA was used to compare the means of hospitalization duration between age
groups to determine if disease severity is similar or significantly different across age groups. The
same linear and ANOVA analysis methods were conducted to compare the four identified agerisk groups of this study. To account for non-normal data, a non-parametric method was utilized.
The Kruskal-Wallis test was used to compare hospitalization duration among the eight acute-care
hospitals located in Hidalgo County. This test method was also used for hospitalization duration
and age-risk group.
Finally, for this 2nd hypothesis, case fatality was also analyzed to determine if any
specific population groups or other factors contribute to final patient outcome. Descriptive
statistics examined overall mortality and also specifically by infection type and age group. A
binary logistic model was run to assess mortality with age and sex. This logistic regression was
conducted to statistically identify if certain age-risk groups were more at risk for a morality
outcome.
3rd Hypothesis Methods: Spatial Analysis of IPD Incidence
The third hypothesis examined the influence of socioeconomic status and disease
incidence. Socioeconomic status was defined by median household income. This data variable is
defined at the population level of census tracts. Hidalgo County has 113 census tracts, and
United States Census Bureau data was incorporated to assess if income influences invasive
pneumococcal disease risk and incidence.
Census tract information was collected from the United States Census Bureau. This
information provided demographic data for the population of interest. The mapping software was
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first layered with a base layer of the county. This included layering a .shp file to place the county
and its census tract boundaries onto the map. The .kml file type is a Keyhole Markup Language
file for geographic annotation and visualization. Shapefiles (.shp) were extracted from the United
States Census Bureau to create a mapping vector layer for the census tracts within Hidalgo
County. Other boundary shapefiles and .kml files were received from the Hidalgo County Health
and Human Services Department and Hidalgo County Planning Department.
Population-level information was collected from the American Community Survey
(ACS) from the United States Census Bureau. This included the median household income,
average household size, private health insurance coverage (%), and land area. Land area (square
miles) was collected to calculate population density. The total land area for each census tract was
divided by the population estimate of the ACS. A new datasheet was created to combine the
population-level data from the ACS. The incidence rate was also included. This was calculated
by creating a case count per census tract. The count was then divided by the 2016 population
estimate of the census tract. This created the initial incidence variable. Next, the incidence was
multiplied by 10,000 and created as an additional variable, IncidenceX10,000. This was
completed to provide a more workable numerical figure and to determine case incidence per
10,000 individuals. The range of incidence was calculated from both the cities and census tracts.
The incidence of cities was also compared with one another.
To begin, descriptive statistics were analyzed to present data on the census tracts and
their characteristics. Techniques included examining range, mean, and median of the associated
census data. The population variables studied included median household income, private
insurance coverage, household size, and population density. The mean and population range,
minimum and maximum values were calculated from the census tracts. The mean and range were
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also calculated for the median household income, private health insurance coverage, and
household size.
Economic and spatial analysis. Economic and spatial analysis was conducted to support
the third hypothesis. Spatial analysis was performed to create data visualization of the statistical
outcomes. Data was collected from an information exchange with Hidalgo County, which
included geographical variables (i.e., census tract and city). Since all geographical data derived
from one county, no identifiable information was depicted. Techniques were used to ensure to
stay in compliance with the Health Insurance Portability and Accountability Act (HIPAA).
Geocoding was used so that the extracted data from Hidalgo County Health and Human Services
Department (HCHHSD) did not contain any identifiable information connecting a patient to
disease. This included using broader measurements, such as census tract and city, instead of
patient address.
As mentioned earlier, ArcGIS version 10.6 was used as the software platform for the
spatial analysis component of this data. To begin, new variables were created to intersect case
count and population density. Census tracts were used as a marker for economic impact for
disease. Although individual patient income was not be collected, census tract of residence was.
Therefore, data was analyzed by comparing census tract median household incomes with the
occurrence of disease. Population density was analyzed along with incidence, rather than case
counts, so that a larger population did not create a bias in the statistical outcomes. This was
accomplished by creating a variable, CTIncidence, so that there is an incidence calculated for
each census tract studied. This incidence was calculated based on case and population data.
Performing this analysis helped determine if income levels have an influence on disease risk.
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The shapefile of Hidalgo County census tracts was attempted to be joined to the Excel
data of incidence and socioeconomic data. However, the data would not join. Therefore, the
attributes and properties of the shapefile were reviewed and identified to be string data.
Therefore, the census tract labels and names were converted from numerical text values to text so
that it could be recognized in the join step of ArcGIS. A unique ID integer variable was required
to perform OLS. This was created and established in Excel.
A choropleth was mapped on case incidence for the census tracts in Hidalgo County. As
with the table earlier, case incidence for this choropleth was calculated per 10,000 individuals.
Then a series of choropleths were created to depict six of the explanatory variables of interest.
Hot and cold spot analysis was performed, based on incidence within each census tract. A
median and a mean center were also mapped to describe the center of overall disease
representation. Next, spatial autocorrelation of variables was performed, utilizing Moran’s index.
This was utilized to identify the presence of case clustering among census tracts for the
following variables: median household income, average household size, private health insurance
coverage, population density, high school completion, bachelor’s degree completion, Hispanic
ethnicity, and foreign-born representation. Case incidence was also examined in the spatial
autocorrelation analysis.
Next, ordinary least squares (OLS) was conducted to examine the four explanatory
variables of interest and their overall relationship to case incidence in each of the census tracts.
These seven explanatory variables included median household income, private health insurance,
household size, educational attainment, ethnicity, foreign-born representation, and population
density. An OLS model was created, incorporating all seven explanatory variables to explore if
any had significant outcomes. Once the model was run, the following was identified: median
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household income and private health insurance coverage were of interest to identify if any
relationships existed with socioeconomic status and health insurance coverage in regards to
disease incidence.
Geographic weighted regression was performed as an additional method for analysis. In
this model, the same four variables (median household income, private health insurance,
household size, and population density) were included within the analysis. Finally, a linear
regression model was conducted in Stata to compare to ArcGIS and to test the null and
alternative hypotheses. This linear regression model examined the incidence of the 112 census
tracts with median household income. This included comparing the two continuous variables of
income and incidence rate.
Summary
In summary, this research was a cross-sectional epidemiological study. The population
assessed was represented through patients of invasive pneumococcal disease in Hidalgo County,
Texas, a United States-Mexico border community. Through the establishment of a memorandum
of understanding, data was exchanged and collected from Hidalgo County Health and Human
Services Department. This dataset was utilized for secondary analysis to identify risk population
for invasive pneumococcal disease. Primarily, this research study focused on age demographics,
risk factors, and socioeconomic influences to determine presence of increased incidences of
disease. This research study was conducted to identify which populations are at most risk for
infections and whether these groups align with current vaccine recommendations.

CHAPTER FOUR: RESULTS
The primary objective of this research study was to examine the disease burden and
population characteristics for infection of invasive pneumococcal disease. More specifically, this
included identifying if certain age groups were most susceptible to infection and which groups
were at higher risk of severe complications of infection. Furthermore, other research objectives
included comparing subpopulations to identify if socioeconomic factors contribute to disease
incidence. This included utilizing United States census data along with spatial analytics to
determine population-based risk factors for disease. Population density, household size, median
household income, and private health insurance coverage were data variables analyzed from the
United States Census Bureau.
The first step before data abstraction was completing the Institutional Review Board
(IRB) submission process. A screening application for IRB was submitted to Northern Illinois
University’s Research Compliance Office. From there, it was identified that this research project
did not encompass human subject research, as described in their determination notice. This then
allowed for official data abstraction from Hidalgo County.
Data Collection
Data was abstracted from Hidalgo County Health and Human Services, located in
Edinburg, Texas. This data information exchange process included a dataset transfer, where all
identifiable information was completely omitted from the report. Identifiable information that
was excluded from this exchange included, but was not limited to, patient name, patient address,
and patient phone number. This data information exchange took place through a memorandum of
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understanding (MOU) with Hidalgo County to exchange de-identified data for the purposes of
this research project. A total of 333 records were obtained in a comma space value file. This
dataset included the variables from the public health case investigations conducted by Hidalgo
County Health and Human Services for invasive pneumococcal disease case reports from 2010
to 2016. Case investigations conducted by the epidemiology and surveillance team at HCHHS
included gathering and collecting medical history, risk factors, vaccination status, and disease
outcomes. The cases were reported from medical providers who had a positive culture of
Streptococcus pneumoniae in a patient residing in Hidalgo County.
Data was also collected from the United States Census Bureau. This included
demographical data of Hidalgo County and its census tracts. The American Fact Finder was used
from the U.S. Census Bureau to access the American Community Survey (ACS) data. A total of
five datasets were extracted from this data source. The variables extracted from these datasets
included population estimate, median household income, average household size, private health
insurance coverage, population density, educational attainment, Hispanic representation, and
foreign-born representation. Once completed, all data components were compiled into a single
Excel spreadsheet for additional analysis.
Data Cleanup
As an initial step of data cleanup, the comma space value file of the epidemiology dataset
was first converted and saved to an Excel spreadsheet to allow for edits and changes to be saved.
In the pneumococcal disease datasheet, there were a total of 140 variables (columns) and 333
case patients (rows). Of the 140 columns, 59 were background geospatial data. This included
examples like geocoding source and census that were not directly actively involved with the
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analysis of data. In addition, many variables were duplicated to account for variations in data
analysis, such as conversion into categorical, binary, or string variables.
Some variables required data cleanup, such as hospital discharge dates. A total of 241
cases were identified as hospitalized. Of these cases, 75 had a missing discharge date. An
analysis of pattern for missing data was completed to identify if any trends existed in discharge
dates missing. A subsection of late 2016 cases were identified with this pattern. Furthermore, the
comment variable of the dataset was reviewed and cross-referenced to identify potential common
reasons for missing discharge dates. Comments included the patient still being hospitalized at the
time of the case being completed and closed, as well as notation of expiration. A total of six cases
had notation of the patient expiring. Of these six cases, four were admitted into a hospital, and
these discharge dates were updated to reflect this information. In addition, a retrospective review
was initiated with Hidalgo County to limit the missing values.
Data cleanup also included verifying all other variables that may have had missing
information. For example, if there was mortality information, such as deceased date and time, the
deceased indicator was updated from blank to yes. Another example included if the comment
section included the specific comorbidities and risk factors, this was then transferred and
recorded into the appropriate variables.
Demographic data was then reviewed for completeness. Age, sex, city, census tract, and
zip code were all complete, with zero missing values. City, zip code, and census tract
information was also cross-verified to ensure that all values correlated to correct values that
could be located within Hidalgo County, Texas. This encompassed comparing these variables’
data entry fields with the United States Census Bureau’s defined jurisdictions within Hidalgo
County.
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Another section of data cleanup encompassed string variable conversion. In instances
where string variables were provided, an additional variable was created as a numerical value.
One example of this included assigning a hospital ID. Each hospital name was assigned an
identification number. The variables Hospitalized was numerically assigned zero for no, and one
for yes. Gender was assigned a zero for females and a one for males. For the variable AdultGeri,
adults were assigned a zero and geriatrics a one. Zero and one were selected as the binary values
to allow for binomial and other numerical testing. Variable categories were also named and
assigned to align with the hypotheses of this research study. The numerical age value was
assigned an age category. This included an additional age category that was created for all three
age groups, AgeCategory, representing pediatric (1) for under 18 years old, adult (2) for 18-64
years old, and geriatric (3) for 65 years and over.
Within the Excel database containing the United States Census Bureau census tract
information, variables were reviewed and cleaned. A foundational dataset was established by
creating a variable of all census tracts in Hidalgo County. A total of 18 variables were created,
encompassing both Hidalgo County case data and American Community Survey (ACS) data.
This included, but was not limited to, population estimate, median household income, average
household size, private health insurance coverage, land area, population density, educational
attainment, ethnicity representation, foreign-born representation, case count, and incidence.
A total of 333 observations were identified in Stata. A pivot table was performed in Excel
to identify any duplication of case identification numbers. A total of four patients had two
infections during this study’s timeframe. Therefore, the second infection was removed for the
purposes of this study’s data analysis. This was completed to prevent bias in the occurrence of
infection representation.
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Data was then imported into Stata to begin analysis. The Stata/IC version 14.2 software
package was utilized for the data analysis of this study. This was accomplished by importing the
dataset as an Excel spreadsheet, with the first row marked as variable headers. The dataset was
also imported into ArcGIS for further spatial analysis.
Overview of Data
A descriptive statistical analysis was performed to identify overall findings of the data. A
total of 329 unique cases were identified in Stata. Four cases were identified to have two
infections each. Therefore, the latter infection was removed from all further analyses to prevent
bias or data inflation. For this dataset, the range of annual case counts was as low as 35 cases in
2010 to as high as 59 in 2011 (see Figure 1). Other annual disease characteristics, such as sex,
ethnicity, underlying conditions, hospitalization duration, deceased indicator, and infection type,
were reviewed (see Table 2).

Annual Case Count of Invasive Pnuemococcal Disease
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Figure 1: Annual Case Count of Invasive Pneumococcal Disease. Cases defined by Texas
DSHS Epidemiology Case Criteria Guide.
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Table 2: Population Demographics and Characteristics
2010

2011

2012

2013

2014

2015

2016

Cases

35

59

47

54

41

46

51

Sex (n)
 Male
 Female

20
15

28
31

24
23

27
27

22
19

23
23

29
22

Median Age

52.0

50.0

61.0

58.0

60.0

57.5

59.0

31
88.57%

50
84.74%

39
82.98%

40
74.07%

38
92.68%

37
80.43%

43
84.31%

7
20.00%

38
64.41%

32
68.09%

39
72.22%

33
80.49%

33
71.74%

28
54.90%

1.667

4.810

4.625

5.963

12.294

10.441

6.324

3
8.57%

6
10.17%

2
4.65%

3
5.56%

2
4.88%

3
6.52%

3
5.88%

33
2
0

52
1
6

42
1
0

53
1
0

40
1
0

45
1
0

51
0
0

Hispanic/
Latino Ethnicity
Underlying
Conditions
Present
Avg.
Hospitalization
duration (Days)
Deceased
(n / %)
Infection Type
(n)
 Bacteremia
 Meningitis
 Other

The overall median age of the seven-year data set was 57.00 years old, with a mean of
48.81 years. Age of cases ranged from as young as 3 days old to up to 100 years old. The 25th
percentile age was 26, and the 75th percentile was 73 years old. The youngest median age
occurred in the year 2011 at 50 years old, and the oldest median age in 2012 at 61 years old.
These trends were also graphed annually to show the annual distribution of age through box plots
(see Figure 2). This figure also depicts where in 2011 and 2016 a larger proportion of pediatric
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cases under the age of five occurred. The primary race and ethnicity was Hispanic/Latino with
90.27% of cases (n=297), and 9.73% as not Hispanic/Latino (n=32).

Figure 2: Annual Age Distribution of IPD Cases
For the seven-year period, 157 cases (47.72%) were female and 172 cases (52.28%) were
male. The year 2011 was the only year when the female case count (n=31) was higher than the
male case count (n=28). Of the 329 cases of invasive infection, 96.05% (n=316) were bacteremia
infections, 2.13% (n=7) were meningitis infections, and 1.82% (n=6) were either classified as
other or unknown infections. Cases occurred primarily in the fall and winter months. December
had the highest monthly average (7.43 cases), and June had the lowest monthly average (1.86
cases). December 2014 had the highest case count frequency, occurring in a single month. Cases
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were four times (4.0000) more likely to occur in December versus June. The months of May to
August presented the lowest overall case counts (see Figure 3).

Annual Seasonal Trends of IPD Cases
Hidalgo County, Texas
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Figure 3: Annual Seasonal Trends of IPD Cases. Dates defined by specimen collection date.
Hypothesis 1 Results: Vaccine Eligibility in Cases
As identified in the methods section, the following is the first null and alternative hypotheses.
H0: The vaccine-ineligible adult population (18-64 years) has no significant difference in the
probability of pneumococcal disease, as compared to vaccine-eligible populations (H0: pvi < pve).
H1: The vaccine-ineligible adult population (18-64 years) has a significant difference in the
probability of pneumococcal disease, as compared to the vaccine-eligible populations (H1: pvi ≥
pve). These hypotheses focus on vaccine eligibility and disease probability within these
subgroups of the population.
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Age and Comorbidities
A total of 329 cases had a numerical age that was transcribed into either pediatric, adult,
or geriatric. As mentioned earlier, AdultGeri was another variable established for binary analysis
of the adult and geriatric populations. Over the seven-year timespan, the adult age group was
most common, with 131 cases, followed by geriatric (n=121) and pediatric (n=77). The three age
categories (pediatric, adult, and geriatric) were described by sex, race, and infection type (see
Table 3). The 18-64 age group was the most common for males, females, and Hispanic ethnicity.
Non-Hispanic ethnicity was the most common, by both count and rate, among the 65 years and
older age group.
Table 3: Age Category Characteristics and Distribution
Parameter (Age Category)


Sex



Ethnicity



Infection Type

0-17

18-64

65+

Male
Female

45 / 58.4%
32 / 41.6%

64 / 48.9%
67/ 51.1%

63 / 52.1%
58 / 47.9%

Hispanic
Non-Hispanic

74 / 96.1%
3 / 3.9%

120 / 91.6%
11 / 8.4%

103 / 85.1%
18 / 14.9%

Bacteremia
Meningitis
Other

75 / 97.4%
1 / 1.3%
1 / 2.3%

124 / 94.7%
5 / 3.8%
2 / 1.5%

117 / 96.7%
1 / 0.8%
3 / 2.5%

The presence of underlying conditions was assessed. Of the overall population, 62.61%
(n=206) had at least one underlying condition documented. Documented underlying conditions
included, but were not limited to, diabetes mellitus, renal failure, liver cirrhosis, heart disease,
heart failure, chronic lung disease, and cancer. Binary logistic models were used with these
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underlying conditions as independent variables and with each hospitalization status and mortality
as the dependent variable. To meet the criteria of having an underlying condition in this study,
the case patient needed one more of the conditions noted above. Underlying conditions did not
significantly increase the risk of mortality, with an odds ratio of 1.048 (p = 0.918). However,
there was a significant increase in the odds of hospitalization for those with underlying
conditions, with an odds ratio of 2.19 (p = 0.02).
𝑝ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑒𝑑
𝑙𝑜𝑔𝑖𝑠𝑡𝑖𝑐(𝑝ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑒𝑑 ) = log (
) = 𝛽0 + 𝛽1𝑋𝑐𝑜𝑚𝑜𝑟𝑏𝑖𝑑𝑖𝑡𝑦
1 − 𝑝ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑒𝑑
𝑙𝑜𝑔𝑖𝑠𝑡𝑖𝑐(𝑝𝑑𝑒𝑐𝑒𝑎𝑠𝑒𝑑 ) = log (

𝑝𝑑𝑒𝑐𝑒𝑎𝑠𝑒𝑑
) = 𝛽0 + 𝛽1 𝑋𝑐𝑜𝑚𝑜𝑟𝑏𝑖𝑑𝑖𝑡𝑦
1 − 𝑝𝑑𝑒𝑐𝑒𝑎𝑠𝑒𝑑

Vaccine Eligibility
A variable for vaccine eligibility was created as a dichotomous variable. This included a
value of 1 for “yes” and a value of 0 for “no” in regards to a vaccine indication for the
pneumococcal vaccine. This eligibility was determined by current 2010 to 2016 vaccine
recommendations and patient risk factors, such as age and comorbidities. All 329 cases were
assigned a vaccine eligibility status. This was accomplished by reviewing medical risk factors in
the case data entry, the age, and other social risk factors that determined ACIP and CDC vaccine
indications. Of the 329 cases, 321 cases were included in hypothesis testing. Eight of the cases
were identified as having disease exposure prior to two months of age, making them ineligible
for vaccination, and therefore were excluded from this portion of the analysis to not misrepresent
disease risk in the vaccine-eligible pediatric population.
Vaccine eligibility was analyzed for a total of 321 case infections. A total of 37 (11.53%)
patients had an identified vaccination history from the case investigation outcomes. A total of
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284 (88.47%) patients had no vaccine history identified within the case findings. However, after
review of age, comorbidities, and risk factors, an additional 195 patients were eligible for
vaccination. Of these 195 patients eligible but not vaccinated, 119 were 65 years or older. In
addition, 38 patients were 18 to 64 years old with at least one indicated risk factor. Finally, an
additional 38 were pediatric patients with no previous vaccine history identified.
A chi-square cross tabulation table was created to compare the frequency of vaccine
history and vaccine eligibility. The Pearson chi-square test equaled 10.8380, with 1 degree of
freedom. This resulted in a significant p-value from both Fisher’s exact test (p < 0.0005) and the
chi-square test (p = 0.001), presenting dependence among vaccination eligibility and history (see
Table 4).
Table 4: 2X2 Table of Vaccination History and Vaccine Eligibility
Vaccine Eligibility
Vaccination History
Count

Vaccine Ineligible Vaccine Eligible

Total

89

195

284

31.34%

68.66%

88.47%

2

35

37

5.41%

94.59%

11.53%

91

230

321

100%

100%

100%

Not
Vaccinated
%

Count
Vaccinated
%

Count
Total
%
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The two cases that were vaccinated without indication included two cases (aged 60 and
62) who did not have any documented risk factors. An additional case was identified from the
eight infant cases, where one infant just under two months was also vaccinated slightly before
the vaccine-indicated time frame age of two months.
To test the first hypothesis, the binomial probability test was selected as the inferential
statistic function to compare the expected probability of subgroups of invasive pneumococcal
disease cases with one another. First, the binomial test examined the adult versus geriatric age
groups to identify if there was any significant difference between the two groups. This analysis
looked specifically at age and did not compare comorbidities or other health risk factors. A total
of 252 observations occurred, with an expected k of 126 cases. A total of 121 cases were
observed as geriatric cases and 131 as adult cases. Therefore, the observed probability of
geriatric case occurrence was 0.4802, compared to the assumed probability of 0.5000.
Furthermore, there was no significant difference (p = 0.2854) in case occurrence between adult
and geriatric patients when no other contributing risk factors are considered.
𝑃(𝑋) =

𝑛!
× (𝑝) 𝑋 × (𝑞)𝑛−𝑋
(𝑛 − 𝑋)! 𝑋!

A binomial probability test was also performed to determine if there was no significant
difference in case probability between the vaccine-indicated population and the vaccineineligible population. A total of 321 observations were included in this analysis. Again, eight
cases were removed from this analysis since they did not meet the pediatric age criteria for
vaccination. All eight cases were less than three months old. The probability of success for this
binomial test was set at 0.5 to represent an equal probability between both groups. In this
analysis the observed k for vaccine eligible was 230, with an expected k of 160.5, translating to
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an observed probability of 0.7170. This resulted in a significantly greater case occurrence within
the vaccine eligible subgroup, compared to the vaccine-ineligible subgroup (p < 0.00005).
Finally, a post hoc binomial test was examined specifically for the 18-64 age group. The
case occurrence was compared between the vaccine-eligible and vaccine-ineligible groups.
Between both groups, a total of 131 observations occurred, which resulted in an expected k of
65.5, representing a 0.5 standard equal probability. The case occurrence of the vaccine-eligible
group in this age group was 30.53% (n=40), while the vaccine-ineligible case occurrence was
69.47% (n=91). This resulted in a significantly lesser case count within the vaccine-eligible
subgroup, as compared to the vaccine-ineligible group, among the 18-64 age range (p <
0.00005).
Hypothesis 2 Results: Hospitalization Duration in Risk Groups
In the next section of study, it is of interest where hospitalization and hospitalization
duration is significantly different between the different risk groups, as noted in the following null
and alternative hypotheses. H0: There is no significant difference in hospitalization duration for
pneumococcal disease between the age-risk groups identified (H0: µPedi = µHA = µHRA = µGeri).
H1: There is a significant difference in hospitalization duration for pneumococcal disease
between the age-risk groups identified (H0: µPedi ≠ µHA ≠ µHRA ≠ µGeri). These hypotheses
represent the following four risk groups: pediatric, healthy adult, high-risk adult, and geriatric.
Healthy adult represents adults aged 18-64 years old with no risk factors indicating
pneumococcal vaccination, while the high-risk adult group represents the same age group with
vaccine-indicated comorbidities and risk factors.
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Hospitalization Status
Hospitalization status was also assessed. This was defined as being admitted into a
hospital facility. Emergency departments without admission were not considered as hospitalized.
All 329 records identified with a hospitalization status. Of these cases, 241 (73.25%) patients
were hospitalized, and 88 (26.75%) were not. Of the pediatric group, 47 patients (61.04%) were
hospitalized, and 30 patients (38.96%) were not hospitalized. Of the healthy adult group, 71
patients (78.02%) were hospitalized, and 20 patients (21.98%) were not hospitalized. Of the
high-risk adult group, 30 patients (75.00%) were hospitalized, and 10 patients (25.00%) were not
hospitalized. Of the geriatric group, 93 patients (76.86%) were hospitalized, and 28 patients
(23.14%) were not hospitalized.
A chi-square test of association was performed to compare hospitalization rates of these
groups. With a Pearson’s chi-square of 7.7846 and a p-value of 0.051, this association is not
statistically significant, but it does present a strong trend for the relationship of hospitalization
status along with the age-risk group.
Binary logistic regression was then performed to assess hospitalization status among
high-risk versus generally healthy groups. This regression model resulted in an odds ratio of
2.1870, with a standard error of 0.2493 and a z-score of 4.62. Therefore, there is a significant
increase in the high-risk group (p < 0.005) to be hospitalized over the generally healthy group.
𝑙𝑜𝑔𝑖𝑠𝑡𝑖𝑐(𝑝ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑒𝑑 ) = log (

𝑝ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑒𝑑
) = 𝛽0 + 𝛽1 𝑋𝑅𝑖𝑠𝑘
1 − 𝑝ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑒𝑑

A binary logistic regression model was also fitted to assess the association of age and sex
with hospitalization status. In this model, the risk of hospitalization was not different between
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males and females, with an odds ratio of 1.413 (p = 0.172). However, age showed a significant
association with the risk of hospitalization, with an odds ratio of 1.011 (p = 0.008).
𝑙𝑜𝑔𝑖𝑠𝑡𝑖𝑐(𝑝ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑒𝑑 ) = log (

𝑝ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑒𝑑
) = 𝛽0 + 𝛽1 𝑋𝐴𝑔𝑒 + 𝛽2 𝑋𝑆𝑒𝑥
1 − 𝑝ℎ𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑒𝑑

Hospitalization Duration
For hospitalization duration, 161 patients had both an admission and discharge date.
Hospitalization duration ranged from 1 day to 84 days, with a mean of 8.025 days. Of those
hospitalized, a total of 12 hospitals were identified. Hospitals were categorized into nine
categories, including the eight local hospitals within Hidalgo County and a ninth category to
represent all other facilities outside of the county. Figure 4 depicts a histogram of hospitalization
duration of these nine categories.

Figure 4: Hospitalization Duration by Facility. Ninth category represents other hospitals
outside of Hidalgo County, Texas.
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When examining hospitalization duration, the shortest average duration was Hospital 2
(n=8), with a mean of 4.125 days. The longest average duration was the Other category, Hospital
9 (n=2), with a mean of 22.5 days. The second longest average duration was Hospital 1 (n=52),
with a mean of 10.5 days. Prior to ANOVA, a Shapiro-Wilk test was run in Stata to assess
normality in the variable HospitalDuration. In this analysis, the data was identified to not have a
normal distribution, with a z-score of 9.254 (p < 0.00005). Therefore, caution was taken when
analyzing with one-way ANOVA and linear regression. A one-way ANOVA was performed to
compare hospitalization duration lengths between each hospital. In this model, the ninth hospital
category (Other) was removed, since this included all other hospitals outside of Hidalgo County,
Texas. This ANOVA model resulted in an F statistic of 0.92, indicating no significant difference
in means in the duration between any pair of hospitals (p = 0.4958). The Kruskal-Wallis rank
test, a non-parametric test, was run to compare hospital stay lengths among the eight local
hospitals in Hidalgo County. The chi-squared result was 7.687 with 7 degrees of freedom and a
p-value of 0.3610. Therefore, the hypothesis that these two variables are independent failed to be
rejected.
Now focusing on the patient characteristics, a linear regression model was developed to
examine the association of age with hospitalization duration. Linear regression was fitted using
hospitalization duration as the dependent variable and numerical age as the independent variable.
With an F statistic of 0.99, this model indicated no significant association (p = 0.3224) between
age and hospitalization duration. To account for a non-normal distribution, Spearman’s rank
correlation was analyzed for AgeReported and HospitalizationDuration. In this analysis,
Spearman’s rho equaled 0.0340, with p-value of 0.6681. Therefore, the null hypothesis that both
variables are independent failed to be rejected.

74

𝑌𝐻𝑜𝑠𝑝𝑖𝑡𝑎𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛𝐷𝑢𝑟𝑎𝑡𝑖𝑜𝑛 = 𝛽0 + 𝛽1 𝑋𝐴𝑔𝑒𝑅𝑒𝑝𝑜𝑟𝑡𝑒𝑑 + 𝜀
Data analysis was then executed to account for age-risk factors. As stated earlier, the
population of study was divided into four groups. This included pediatric, healthy adult, highrisk adult, and geriatric. These four groups were divided to identify which groups, if any, had
higher rates of infection and longer hospitalization duration compared to others. The pediatric
group equaled 1, the healthy adult equaled 2, the high-risk adult equaled 3, and geriatric equaled
4. Group 1, pediatric, had 31 cases with a hospitalization duration. This ranged from 1 to 79
days, with a mean of 9.06 days. Group 2, healthy adult, had 43 cases with a hospitalization
duration. This ranged from 1 to 27 days, with a mean of 7.14 days. Group 3, high-risk adult, had
22 cases with a hospitalization duration. This ranged from 1 to 84 days, with a mean of 11.68
days. Group 4, geriatric, had 65 cases with a hospitalization duration. This ranged from 1 to 29
days, with a mean of 6.88 days (see Figure 5).

Figure 5: Hospitalization Duration by Age-Risk Group. Hospitalization in terms of days.

75

Next, a one-way ANOVA was completed to compare age-risk groups regarding
hospitalization duration. With an F statistic of 1.01, the means of hospitalization duration
between the four age-risk groups was not significant (p-value = 0.3894; see Table 5). In addition,
a Kruskal-Wallis rank test was run, resulting in a chi-squared result of 2.667 with 3 degrees of
freedom and a p-value of 0.4459. To further assess hospitalization duration, a one-way ANOVA
model was run incorporating other explanatory variables (i.e., age category, sex, deceased
outcome, Hispanic ethnicity, hospital, vaccination, vaccine eligibility, and underlying
conditions). This was run multiple times for each variable of interest and compiled together.
None of these variables presented significance within their prospective models (see Table 6).
Table 5: Analysis of Variance of Hospitalization Duration (Days) by Age-Risk Group
Source

Mean

Std. Dev.

Freq.

Group 1
(Pediatric)

9.0645161

15.513296

31

Group 2
(Healthy Adult)

6.9285714

6.2053983

42

Group 3
(High-Risk Adult)

10.857143

17.675649

21

Group 4
(Geriatric)

6.8769231

5.5297708

65

Total

7.8427673

10.475127

159

Source

SS

df

MS

F

Prob>F

Between groups

332.825687

3

110.941896

1.01

0.3894

Within groups

17004.2435

155

109.704797

Total

17337.0692

158

109.728286
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Table 6: Analysis of Variance of Hospitalization Duration by Explanatory Variable
Source

Partial SS

df

MS

F

Prob>F

Age Category

146.798884

2

73.3994421

0.66

0.5207

Current Sex

27.6018976

1

27.6018976

0.6204

0.6204

Deceased

343.916138

1

343.916138

3012

0.0790

Hispanic Ethnicity

72.3576987

1

72.3576987

0.65

0.4223

Hospital ID

1130.57497

8

141.321872

1.29

0.2552

Vaccinated

50.9934727

1

50.9934727

0.46

0.5007

Vaccine Eligible

251.239752

1

251.239752

2.27

0.1338

Underlying Conditions

1240495027

1

124.495027

1012

0.2922

Case Fatality
The case fatality rate of each group was also of interest for review. A total of 22 (6.69%)
cases of the 329 cases resulted in fatality. The other 307 cases (93.31%) had no documentation of
mortality. Of the fatal outcomes, all 22 cases (100%) derived from bacteremia infections; no
meningitis cases resulted in fatality. The case fatality rate for the pediatric group was 7.25%, for
the adult group was 6.87%, and for the geriatric group was 6.61%. The mean age of cases
resulting in mortality was 51.02 years old. The median age was 54.00 years old. The range from
date of positive culture to date of death ranged from 0 days to 27 days. The mean of this time
period was 3.45 days and the median was 1 day. A binary logistic model was run to assess
mortality with age and sex, resulting in no significant association. Age presented an odds ratio of
1.003 (p = 0.727), and sex presented an odds ratio of 0.912 (p = 0.834).
𝑝𝑑𝑒𝑐𝑒𝑎𝑠𝑒𝑑
𝑙𝑜𝑔𝑖𝑠𝑡𝑖𝑐(𝑝𝑑𝑒𝑐𝑒𝑎𝑠𝑒𝑑 ) = log (
) = 𝛽0 + 𝛽1 𝑋𝐴𝑔𝑒 + 𝛽2 𝑋𝑆𝑒𝑥
1 − 𝑝𝑑𝑒𝑐𝑒𝑎𝑠𝑒𝑑
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Hypothesis 3 Results: Spatial Analysis of IPD Incidence
The third hypothesis in this study examined population-level data to compare other
potential risk factors. This is more specifically defined in the following null and alternative
hypotheses. H0: Within the population of study, lower income populations have no increased risk
in the rate of infection for invasive pneumococcal disease (H0: Β1 = 0). H1: Within the
population of study, lower income populations have an increase risk in the rate of infection for
invasive pneumococcal disease (H1: B1 ≠ 0).
A total of 113 census tracts were identified in Hidalgo County, Texas, from the United
States Census Bureau. Census tract names ranged from 201.01 to 246.00, with the exception of
census tract 9800, which represents the McAllen Miller International Airport. No cases were
reporting with this census tract. In addition, 27 zip codes and 22 cities were identified in Hidalgo
County, Texas.
Population Data Results
United States Census data was collected using the American Community Survey (ACS)
for the census tracts in Hidalgo County. The known information from the dataset included the
case count per census tract. The total population for each census tract was extracted from the
ACS in the American FactFinder of the U.S. Census Bureau. The average population of all
census tracts in Hidalgo County was 7,396 people. Population of the 112 census tracts, excluding
census tract 9800 with a population of zero, ranged from as low as 1,002 people in census tract
243.02 to as high as 17,165 people in census tract 240.00.
The average median household income for all census tracts was $36,182. The median
household income of all census tracts in Hidalgo County was $32,819. This ranged from as low
as $18,274 in tract 241.12 to as high as $76,971 in tract 235.10. Private health insurance
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coverage averaged out to 33.65% for all census tracts, with a median of 29.50%. This ranged
from as low as 10.40% in tract 241.12 to as high as 75.4% in tract 209.01.
Average household size and population density were of interest to determine if any
relationships existed between an increase in person-to-person contact and disease incidence. The
average household size of all census tracts was 3.59 individuals per household. Per census tract,
this figure ranged from as low as 2.29 in tract 241.11 to as high as 5.03 in tract 205.1.
Next, the incidence was calculated for each census tract and multiplied by 10,000 to represent an
incidence per 10,000 people. The incidence of cases ranged from as low as zero in multiple
census tracts to as high as 17.57 per 10,000 people in census tract 204.03. Incidence was also
measured for each of the 22 cities located in Hidalgo County, Texas. Of the 329 cases, three were
removed due to not being located within a city. Of the 326 cases reviewed in their respective
cities, the lowest incidence was zero cases. This included Granjeno, La Villa, Palmhurst,
Progreso, and Progreso Lakes, Texas. The lowest calculative incidence was 1.74 cases per 10,000
people in Alton, Texas. The second highest incidence was 8.88 cases per 10,000 people in
Mission, Texas, and the highest incidence was 17.83 per 10,000 people in Edcouch, Texas. This
city also had an incidence 3.934 times greater than the average incidence for all cities. Each
city’s incidence was also calculated and compared (see Table 7).
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Table 7: IPD Case Incidence Rates per City
City
Alamo
Alton
Donna
Edcouch
Edinburg
Elsa
Granjeno
Hidalgo
La Joya
La Villa
McAllen
Mercedes
Mission
Palmhurst
Palmview
Penitas
Pharr
Progreso
Progreso Lakes
San Juan
Sullivan City
Weslaco

Incidence per 10,000
7.11418263
1.73631207
7.81343912
17.83060921
6.09215773
4.20521447
0
2.87129424
4.66635558
0
4.5551382
1.79275726
8.88372975
0
5.17955801
8.18665575
5.03226943
0
0
6.21940997
4.81579581
2.72560583

Spatial Analysis Results
To perform spatial analysis for this study, ArcGIS (ArcMap) version 10.6 was used. First,
a general choropleth was created to present the distribution of incidence across Hidalgo County.
Next, a spatial autocorrelation (Moran’s index) was completed to determine significance between
dispersed, random, or clustering of incidence outcomes. Once run, with a z-score of 1.7943, this
choropleth presented strong associations towards spatial clustering (p = 0.0727). Subsequent
choropleths depict population-level explanatory variables, such as population density (per square
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mile), median household income, private health insurance coverage, education, and ethnicity
representation (see Figure 6). Next, high-low clustering (Getis-Ord general G) analysis was run
to assess cluster patterns among case incidence. This analysis resulted in an observed G score of
0.000083. Therefore, a significant pattern was observed of a high-clustered pattern in regards to
case incidence per census tract (p = 0.0045).

Figure 6: Choropleths of IPD Case Incidence Rates and Population Variable. Case
incidence rates per 10,000 people. Continued on following page.
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Figure 6 continued.
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Next, a hot and cold spot analysis was performed, based on incidence rates within each
census tract. Census tracts were statistically color coded to identify both hot and cold spots for
incidence. The darker red areas describe hotspots and the darker blue areas represent coldspots.
The yellow circle represents the median center for incidence. The green circle represents the
mean center for incidence. Those shaded in dark red represent census tracts with a p-value less
than 0.01 for high incidence coverage. The census tract shaded dark blue also represents a pvalue less than 0.01 for low incidence coverage (see Figure 7).

Figure 7: Hot and Cold Spot Analysis by Incidence Rates.
Spatial autocorrelation of variables (Moran’s index) was also performed on the
population-level variables and on case incidence. All explanatory variables presented with
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significant results (p < 0.00005), presenting clustering based on these population attributes (see
Table 8). Therefore, it can be interpreted that the independent variables of interest for this
analysis present significant spatial association in regards to the clustering among the census
tracts. Case incidence did not present significant clustering among census tracts (p = 0.7276).
Table 8: Spatial Autocorrelation of Variables

Variable
MedianHHI
AvgHHSize
PrivateHInsurance
PopDensity
CensusIncidencex10,000
HighSchoolorHigher(%)
BachorHigher(%)
Hispanic(%)
Foreign-Born(%)

Moran’s Index

Z-score

P-Value

0.087268

6.594138

0.000000

0.055591

4.396873

0.000011

0.099732

7.414162

0.000000

0.260318

18.367830

0.000000

0.017161

1.794334

0.072760

0.141476

10.237786

0.000000

0.169649

12.222716

0.000000

0.078939

6.006147

0.000000

0.128167

9.330242

0.000000

Next, ordinary least squares (OLS) was conducted, using ArcGIS, to examine the four
explanatory variables of interest and their overall relationship to case incidence in each of the
census tracts. These four explanatory variables included median household income, private
health insurance, household size, and population density. An OLS model, using the Getis-Ord
(Gi*) statistic, was created incorporating all four explanatory variables to identify pattern
detection. Once the model was run, the following was identified. Private health insurance had a
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coefficient of 0.00329, resulting in no significant relationship (p = 0.4873) with incidence.
Average household size had a coefficient of 0.042242, resulting in no significant relationship (p
= 0.4756) with incidence. Median household income had a coefficient of -0.000010, depicting a
strong trend relationship (p = 0.0651) with incidence. Finally, population density had a
coefficient of 0.000056, resulting in a significant relationship (p = 0.0057) with incidence. Since
population density depicted a significant association, an additional OLS spatial analysis was
completed specifically for this variable (see Figure 8).

Figure 8: Ordinary Least Squares of Population Variables.
Spatial autocorrelation was conducted on the ordinary least squares model residuals
above. In this technique, Morin’s index was used, resulting in a value of -0.011547. With a pvalue of 0.862269, no significant clustering was identified. Therefore, it can be concluded that
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this was a result of random outcomes. Furthermore, this ordinary least squares model presented
two independent variables of significance. Median household income (p = 0.0398) and
population density (p = 0.0129) both noted a significant association with the invasive
pneumococcal disease case incidence (see Table 9).
Table 9: Ordinary Least Squares Model Results

Variable

Coef.

Std.
tError Statistic

Prob.

Robust Robust Robust
_SE
_t
_Pr

Intercept

8.3372

8.7940

0.9481

0.3453

9.4515

0.8821

0.3798

--------

Median
HHI

-0.0001 0.0001

-1.9802

0.0503

0.0001

-2.0822

0.0398*

4.6685

AvgHH
Size

0.4992

0.6204

0.8046

0.4229

0.6204

0.8046

0.4229

1.1475

PrivateH
Insurance

0.0596

0.0702

0.8482

0.3983

0.0706

0.8430

0.4012

8.8431

Pop
Density

0.0006

0.0002

2.9761

0.0036*

0.0002

2.5298

0.0129*

1.1686

-1.2593

0.2108

0.0732

-1.2704

0.2068

9.5097

1.0835

0.2811

0.0843

1.0272

0.3067

7.6587

-0.1170

0.9071

0.0727

-0.1036

0.9177

2.3726

-0.0792

0.9370

0.0698

-0.0722

0.9426

1.8677

Census
Incidence -0.0930 0.0739
x10,000
High
Schoolor 0.0866 0.0799
Higher(%)
Bachor
-0.0075 0.0644
Higher(%)
Hispanic
(%)

-0.0050 0.0636

VIF

Geographically weighted regression was performed as an additional method for analysis.
This form of analysis was selected to explore local relationships of the variables of interest. In
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addition, this method was selected to account for the significant spatial clustering of the
explanatory variables of interest for this analysis. In this model, the same four variables (median
household income, private health insurance, household size, and population density) were
included within the analysis. Figure 9 shows the categories of standard residuals for this model
analysis. Furthermore, the local R2 values were assessed for this geographically weighted
regression model. Figure 9 was developed to depict the GWR model’s fit, where areas with
values closer to zero represent poorer performance of the local model.

Figure 9: Geographic Weight Regression of Incidence Rates. Four GWR variables
include median household income, private health insurance, household size and
population density.
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Figure 10: Local R2 of Geographically Weight Regression of Incidence Rates
Finally, a linear regression model was conducted in Stata to compare to ArcGIS and to
test the following null and alternative hypotheses: H0: Β1 = 0 and H1: B1 ≠ 0. This linear
regression model examined the incidence of the 112 census tracts with median household
income. As a four-explanatory-variable model, this resulted in a coefficient of 0.000056 and
standard error of 0.0000199 for population density; thus reporting a significant relationship, with
a p-value of 0.006. In addition, median household income showed a slight trend association (p =
0.065) as well, with a coefficient -9.56e-6. Once this model was amended to a single-variable
model, it resulted in a coefficient of -6.26e-6 and standard error of 2.70e-6 for median household
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income; thus reporting a significant p-value of 0.022 (see Table 10). The equations below
represent this linear regression model of median household income as both a four-variable and
single-variable model.
𝑌𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 = 𝛽0 + 𝛽1 𝑋𝑀𝑒𝑑𝑖𝑎𝑛𝐻𝐻𝐼 + 𝛽2 𝑋𝐴𝑣𝑔𝐻𝐻𝑆𝑖𝑧𝑒 + 𝛽3 𝑋𝑃𝑟𝑖𝑣𝐻𝑒𝑎𝑙𝑡ℎ𝐼𝑛𝑠 + 𝛽4 𝑋𝑃𝑜𝑝𝐷𝑒𝑛𝑠 + 𝜀
𝑌𝐼𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 = 𝛽1 𝑋𝑀𝑒𝑑𝑖𝑎𝑛𝐻𝐻𝐼 + 𝜀
Table 10: Linear Regression of Incidence by Income

Model
MedianHHI

_cons

Coef.

Std. Err.

t

P>|t|

[95% Conf.
Interval]

-0.0000626

0.000027

-2.32

0.022

[-.000116, -9.16e-06]

6.633215

1.037496

6.39

0.000

[4.577142,

8.689288]

Results Summary
In summary, a total of 333 case records were provided by Hidalgo County Health and
Human Services. Of these, four cases represented a second infection later within the seven-year
period. These four cases were removed from analysis. Therefore, a total of 329 observations
(cases) were identified in the dataset. The center patient representation of all cases would be a
57.00 year old (median age) male (more common gender). Of these cases, 241 (73.25%) patients
were hospitalized. Of the 329 cases of invasive infection, 96.05% (n=316) were bacteremia
infections, 2.13% (n=7) were meningitis infections, and 1.82% (n=6) were either classified as
other or unknown infections. Additionally, 22 cases (6.69%) resulted in mortality.
The first hypothesis examined case representation based on vaccine eligibility. First, data
analysis assessed the adult and geriatric population to compare case differences. Although adult
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cases were higher, there was no significant increase (p = 0.2854). Next, adults 18-64 years old
were assessed based on vaccine eligibility. When comparing these two groups, there was a
significant result (p < 0.00005) in greater case occurrence of the vaccine-eligible subgroup,
compared to the vaccine-ineligible subgroup. The second hypothesis assessed hospitalization
duration by comparing and analyzing each of the four age-risk groups. In this test, there was no
statistically significant difference (p = 0.3894) in the means of hospitalization duration between
the four age-risk groups. Finally, the third hypothesis was about population-level characteristics
in invasive pneumococcal disease case incidence. This included variables representing
socioeconomic status and demographics. Both median household income (p = 0.022) and
population density (p = 0.013) presented significant associations with case incidence.

CHAPTER FIVE: DISCUSSION
To complete this research, a retrospective cross-sectional study was developed to assess
the epidemiology of invasive pneumococcal disease in Hidalgo County, Texas. As a quantitative
cross-sectional study, data was reviewed and analyzed from 2010 to 2016 of invasive
pneumococcal disease (IPD). The aim of this research study was to identify the population
characteristics at an increased risk for infection so that preventative health measures could be
targeted and identified. This research was completed to answer the following questions:


With vaccination recommendations established for pediatric, geriatric, and high-risk
populations, is the healthy general adult population still at high risk for infection?



Within this population of study, do high-risk patients experience a longer
hospitalization duration and higher risk of mortality?



Does socioeconomic status, such as household income, influence the rate of disease
within this population?

To answer these questions, this research compared and identified characteristics and
groups at higher risk for infection. In addition, with vaccine recommendations specified towards
certain groups, this research examined the case occurrence and disease outcomes of the different
age-risk groups identified. Finally, this research examined population-level data to conduct
spatial analysis to identify potential trends and patterns of increased incidence.
Findings and Interpretations
The general descriptive statistics within this study identified the salient characteristics of
disease cases. With this descriptive information, it was identified that male infections were more
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common and that the median age was usually in the middle to late fifties each year. Although
case representation can vary from each patient, these two demographics provide a center point of
an invasive pneumococcal disease patient in Hidalgo County, Texas. With the exception of
MMWR Year 2010, annual case counts stayed consistently in the 40s to 50s. However, the three
most recent years have shown an increasing trend line. This increasing case trend line is of
interest since the introduction of a vaccine should be decreasing case rates. In addition, this slight
increase conflicts with the literature, where many areas have shown a decrease in annual cases. A
Rhode Island study presented with a case trend line that consistently dropped annually from 2011
(94 cases) to 2015 (62 cases); (Gosciminski et al., 2017, p. 58). In a study at a Taiwan university
hospital, the incidence of IPD was 3.8 per 10,000 in 2010, decreased to an incidence of 3.1 in
2011, and then to 2.1 in 2012 (Chih-Cheng et al., 2014, p. 6). However, a hospital study in
Guatemala presented with a stable, non-decreasing trend line, similar to Hidalgo County. With
both the hospital’s Santa Rosa and Quetzaltenango departments combined, the case count for
pneumococcal infections changed from 32 cases in 2009, to 27 cases in 2010, to 32 cases in
2011, to 22 cases in 2012 (Contreras et al., 2015, p. 9).
Mortality is another notable feature presented in these data. The literature review
identified that the case fatality rate is estimated to be around 20%, and up to 60% in the elderly,
at the United States national level (CDC, 2015a, p. 280). In the university hospital study in
Taiwan, the overall case fatality rate (CFR) was 30.9%, and the 65 years and older CFR was
40.7% (Song et al., 2013, p. 4). However, the range of mortality was 4.65% to 10.17% during
this study’s time period. Furthermore, the overall case fatality rate for the 65 years and older
population was 6.61% in this study. Therefore, it is of interest to explore what marks these
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notable differences and if long-term tracking is needed to better identify final outcomes in the
local population of south Texas.
Hypothesis 1 Discussion: Vaccine Eligibility in Cases
The age of onset for infection was a variable of interest in this research study. One reason
for this is because the 18-64 age group is the only age group where there is no vaccine indication
on the sole basis of age. In addition, the median age for Hidalgo County (28.8 years) is nearly
nine years younger than the national median age (37.7 years; U.S. Census Bureau, 2017). The
first hypothesis identified that there was no significant difference between the binomial
probability of infection between the adult and geriatric populations (p = 0.2854). With these
findings, it became notable to further explore the subgroups of these two populations. The adult
age group (18-64 years old) represented the largest age group (n=131) of cases of the three age
groups. This age group representation accounted for 39.8% of all cases.
As compared to the literature, a study in Sweden contrasts this finding, where the
geriatric age group (65 and older) represented that largest age group with 51.1% (n=1,521;
Backhaus et al., 2016, pp. 5-7). However, other studies displayed similar descriptive findings to
those within this research study. In a Guatemalan adult pneumococcal study, the majority of
cases, 62.2% (n=117), represented adults 18-64 years, as compared to geriatric patients
(Contreras et al., 2015, p. 6). In addition, similar results were identified in a South Korean study,
where adults comprised 55.2% (n=535), as compared to geriatrics, 44.8% (n=435; Song et al.,
2013, p. 4). These initial findings in this south Texas research study showed concern for this age
group, since this is the only group where age alone is not a vaccine indication. Once other
vaccine indicators, such as comorbidities and risk factors, were accounted for, 38 cases had at
least one vaccine indication, while 89 cases had no vaccine indication. Once vaccine eligibility
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was accounted for, there was a significant difference (p < 0.00005) between the healthy and
high-risk adult groups. Therefore, it was identified that the vaccine-ineligible subgroup had a
significant case representation over the vaccine-eligible subgroup. However, when conducting
binomial testing between the overall vaccine-eligible and -ineligible groups, the vaccine-eligible
group had a statistically significant (p<0.00005) higher proportion of cases (n=230) over the
vaccine-ineligible group (n=91). This resulted in failing to reject the null hypothesis that
infections would be similar among both groups. However, this binomial testing does support the
notion that within the adult population, infections were more commonly occurring in those with
no documented risk factors, as compared to the high-risk group. This presented two notable
outcomes. First, that the generally healthy adult group has an increased risk for infection.
Second, it also identified that lack of vaccination in this high risk-group is a public health
concern in regards to disease prevention.
The vaccination coverage among cases identified that a significant majority were
unvaccinated, as identified through the chi-square association test. This helps identify
introductory risk assessment of vaccine efficacy in this border region. With serotypes varying
globally, concern was presented that those vaccinated were still at great risk for infection. The
highest proportion of unvaccinated persons occurred in the geriatric age group. In addition, as
expected, the findings found vaccinated individuals have lower overall infection case counts.
In a vaccination coverage study in the United States, data from the National Health and
Wellness Study was analyzed. Among those vaccinated for pneumococcal disease, more were
female (60.7%), as compared to male (39.3%; Annunziata et al., 2012, p. 5). Of the 38
vaccinated cases of infection in this research study, more females (n=21) were vaccinated as
compared to males (n=17).

94

In addition to age, comorbidity presence was another variable of interest for this study.
The presence of an underlying condition did not significantly increase the risk of case fatality,
resulting in an odds ratio of 1.048 (p = 0.918). However, there was a significant increase in
hospitalization for having underlying condition(s), resulting in an odds ratio of 2.19 (p = 0.02).
Hypothesis 2 Discussion: Hospitalization Duration in Risk Groups
Utilizing hospital data provided varied opportunities for data analysis of the cases, their
characteristics, and their outcomes. This included incorporating explanatory variables such as
demographics and clinical background to dependent variables like hospitalization status and
hospitalization duration. Explanatory variables, such as age, sex, and underlying conditions,
assessed typical characteristics that could depict increased risk factors for infection.
The second hypothesis examined hospitalization status and hospitalization duration. Of
the 329 patients, 241 (73.25%) had record of hospital admission. A chi-square was performed for
hospitalization status and age-risk groups. A strong trend in the relationship of these two
variables occurred but was not statistically significant (p = 0.051). Therefore, the higher risk and
older populations were more likely to be hospitalized. Next, ANOVA was conducted to compare
the association of hospital facility and hospitalization duration. However, the data was identified
to not be normally distributed through a Shapiro-Wilk test. Therefore, caution was taken in the
interpretation of the ANOVA results, and other non-parametric analysis techniques were utilized
to account for this. However, there was no significant relationship when hospital facility and
hospitalization duration were analyzed through ANOVA (p = 0.4958). The Kruskal-Wallis rank
test depicted no significance as well (p = 0.3610). Therefore, the hypothesis that hospitalization
duration and hospital facility are independent failed to be rejected.
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The current literature is limited on identifying hospitalization status, since the majority
focus on a specific hospital or medical system. However, overall, this study’s hospitalization rate
is lower than those presented in the literature. In a Rhode Island study, 93.04% (n=361) patients
were hospitalized with invasive pneumococcal disease (Gosciminski et al., 2017, p. 58). In a
Sweden study, of the 2,977 episodes of disease, only 25 cases (0.84%) presented as outpatient
(Backhaus et al., 2016, p. 5).
Hypothesis 3 Discussion: Spatial Analysis of IPD Incidence
Spatial analysis of the epidemiology of invasive pneumococcal disease provided the
opportunity to explore and analyze population-based data. This supported the hypothesis
examining socioeconomic status within the population. This included incorporating census data
and utilizing census tracts to better understand population characteristics.
The third hypothesis identified population level-risk factors. To begin, case incidence was
examined at both the city and census tract levels. At the city level, Edcouch, Texas, had the
highest incidence rate at 17.83 cases per 10,000 people. However, when examining this
geographical area at the census tract level, the case incidence rate did not rank among the
highest. Therefore, examining both population levels assisted in giving additional insight on case
occurrence. Furthermore, looking at US Census population level data assisted with incorporating
socioeconomic factors for analysis. When studying human transmission, individuals per
household and population density were examined. As these variables were analyzed, it became
apparent that median household income did have a significant association with incidence. With a
p-value of 0.022 in the linear regression model of case incidence and median household income,
the correlation of these two variables was significant, thus identifying that income has a strong
association with risk of infection within this specific population.
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Patient-specific information was not available on income, household size, or other
instances. Therefore, census tracts were used as a representation for these cases. Therefore, exact
information and analysis directly related to the patient were unable to be performed. This means
that a patient may possibly not align with his or her census tract characteristics for these
variables. However, these data variables do bring insight on notable characteristics that create a
foundation for future research in regards to these relationships. When examining these
explanatory variables through spatial autocorrelation (Moran’s index), a foundation was
established that variables of interest had significant spatial clustering. This included median
household income, average household size, private health insurance coverage, population
density, high school education, bachelor’s degree education, Hispanic ethnicity, and foreign-born
representation (p < 0.00005). Therefore, with each of these variables significantly clustered,
additional analysis could then examine the effect of case incidence.
The hot and cold spot analysis identified the areas with the most concentrated incidence.
This also matched population density. However, since incidence, rather than case count, was
analyzed, the result was not due to the increased population. Once identified, ordinary least
squares (OLS) and geographically weighted regression (GWR) were performed to test the
explanatory variables. Within the ordinary least squares analysis, only population density (p =
0.0129) and median household income (p = 0.0398) had significant findings. Therefore, these
two variables presented significant association with IPD case incidence, resulting in rejecting the
null hypothesis, H0: B1 = 0.
In the spatial analysis of this outcome in OLS, the specific census tracts and their
residuals were visualized through mapping. Therefore, areas of highest residuals could be
identified for future research and analysis. Next, GWR was run to assess a four-variable model
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(i.e., median household income, average household size, private health insurance coverage, and
population density). Performing this GWR model was based on the significant findings from the
OLS analysis so that GWR could attempt to correlate geographical and spatial influences into the
regression analysis. In this analysis under GWR, similar results occurred where population
density presented significant findings (p = 0.006) and median household income presented a
slight trend, not significant, for association (p = 0.065).
Finally, although there is current literature available on the epidemiology of IPD, it is
limited in regards to spatial analysis. Therefore, techniques and methods were of focus for
general infectious disease analysis. In a Massachusetts study, hotspot analysis was performed for
hepatitis C. In this study, Hispanic ethnicity and food stamps (income level) showed significant
spatial hotspots, and a high school education or greater showed a negative association for
infection (Stopka et al., 2017, pp. 4-6).
Outliers in the Data
Throughout the research study, outliers were identified within the data analysis.
Examples of this included the hospitalization duration length in days, where some patients stayed
admitted in the hospital greater than 50 days. The average hospitalization duration for 2010 was
much lower than other years. The sample size for hospitalized was also much smaller, bringing
to question whether data completeness was reliable for this year. Another example included
assessing the cities’ disease incidence, where Edcouch, Texas, has a much greater incidence as
compared to all other cities in Hidalgo County. One of the census tracts did not appear to align
with the others. This was census tract 9800, as compared to all others in the 200’s. There was no
data available from the United States Census Bureau. After researching this census tract, it was
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identified that this census tract is the McAllen International Airport. This census tract was not
included within the spatial analytic methods of this study.
Hospitalization status was recorded for each case within the data set. As identified earlier,
the overall hospitalization rate in this study (73.25%) was much lower than those identified in the
literature. However, 81 of the 88 (92.05%) cases identified as not hospitalized were collected or
reported from a hospital. Therefore, further review by the local health department could help
identify if these patients were ever hospitalized later during their medical visit (e.g., admitted
into the hospital from an initial emergency room visit).
Limitations
Although there was a large representation of hospitalization duration data on cases, many
cases were still missing hospital discharge data. With discharge data missing, a full analysis of
the cases and their outcomes could not be completed. This is especially true since it was
documented in multiple cases that the discharge date was missing due to the patient still being in
the hospital at the time of closing the case investigation. Therefore, it is likely data skewed
towards longer hospitalization durations are more likely to be missing, rather than short
hospitalization duration stays. This creates a concern for data bias and misrepresentation.
The epidemiology case criteria guide for Texas DSHS is reviewed each year. Updates can
include and incorporate new lab technologies, such as CSF PCR. This can then result in an
increase in case identification, now allowing for a probable case definition. This new case status
addition did not take place until MMWR Year 2017. Therefore, no case increases or outcomes
were affected by this amendment. However, as physician may have begun ordering these PCR
labs in the later portion of this timeline, these were positive labs that were never counted as a
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case. This is because they did not meet case definition. Therefore, this study may have not fully
represented PCR cases and instead may only represent culture-based cases.
Limitations also occurred within the spatial analysis component. As an overall
foundation, current research on spatial epidemiology is limited, especially for specific diseases
like invasive pneumococcal disease. Therefore, the literature was abstracted as a foundation in
regards to methods applied, not necessarily the specific disease of analysis. Socioeconomic and
demographic data points such as household size, population density, median household income,
and private health insurance coverage provided introductory information based on the case’s
census tract. However, this did not provide direct correlation to the case itself. This created the
concern of misrepresentation of data for such cases. Furthermore, this could be especially true
with census tracts with few to even single case counts. These census tracts that had minimal case
distribution may also have limited statistical strength in the conducted tests for data analysis. In
addition, some data did not have a normal distribution, as tested through goodness-of-fit. This
resulted in conducting specific forms of statistical analysis, like ANOVA, F-test, and Bartlett’s
test, to account for the distribution patterns.
Recommendations
With overall findings depicting infections in vaccine-indicated populations, increased
vaccination efforts and education are vital to protect high-risk populations. This especially
includes those aged 18-64 years old with at least one risk factor. Once risk factors were assessed
within this age group, it was identified that a strong representation of cases were eligible for
vaccination but had no record of prior history of vaccination. Therefore, targeting vaccination
efforts in this specific subpopulation can help prevent future disease.
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It is recommended that census tract data entry be included within routine investigations
for notifiable disease cases in Texas. Entering this information into the National Electronic
Disease Surveillance System (NEDSS) at time of entry can assist with both outbreak and spatial
analysis. This will prevent epidemiologists and researchers from having to perform post-event
geocoding. Therefore, this could assist in outbreak analysis turnaround time and support analysis
methods staying compliant with HIPAA and other data security protocols.
Another recommendation is to enter discharge dates of notifiable condition
investigations, including invasive pneumococcal disease, that are closed prior to discharge. One
concern of data validity was the discharge dates for cases where the patient was still admitted at
the time of the case closing. This would also assist with case fatality identification. If a patient is
admitted long term, his or her survival outcome may change, affecting the overall case fatality
rate.
It is recommended that lack of vaccine history be documented. Many vaccine history
entries were unknown or blank. Therefore, deciphering between a true no and unknown vaccine
history was difficult. Performing this step can help in determining vaccine efficacy and coverage
in both this disease as well as with other conditions and outbreaks. Furthermore, research such as
this presents the limitation of missing vaccine information. Currently, Texas is an opt-in state for
the state immunization registry, known as ImmTrac. This means, that once a patient turns 19, if
he or she does not opt-in to the system, by signing consent, that vaccine record is removed from
the system. Therefore, tracking adult vaccination history becomes difficult, creating the need for
policy development for the state system to transition towards an opt-out system.
Finally, the last recommendation is to increase funding opportunities for epidemiological
investigation in public health. With many health departments facing limited staff and resources,
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additional funding can assist in epidemiology and surveillance staff completing investigations
fully and accurately.
Researcher Reflections
Prior to this study, it was preconceived through anecdotal information that the general
healthy adult population had a greater risk for infection as compared to other subgroups. This
was of interest, especially since these other subgroups had a vaccine available, creating an
opportunity for decreased disease incidence. Once the study was enacted and data analysis took
place, it became evident that the adult population (18-64 years old) was indeed the more
prominent population for case representation. However, as further analysis took place and this
group was subdivided between healthy and high risk, it was identified that it was the high-risk
group that was dominant. Therefore, these research findings helped identify that although the
general healthy adult population was not at as increased risk as suspected, the vaccine-indicated
adult group was. Furthermore, this better identifies which subgroups need to be targeted for
vaccine education and public health intervention.
Suggestions for Future Research
The first suggestion for future research is to study more patient specific-variables, such as
socioeconomic variables. As mentioned earlier, the socioeconomic data was collected from the
United States Census Bureau and represented the case’s census tract. This is because the type of
data was not collected at the patient level. Future research collecting new data could collect this
same information for each specific patient. By doing so, more accurate representation of case
characteristics can become available.
The second suggestion for future research is to begin incorporating serotype research
collaboration to identify if the border population is at risk for infection not covered by the US
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vaccine. With this population of study residing along the border, it is of interest whether the
serotypes of infection are aligned within the current two pneumococcal vaccines licensed in the
United States. As noted in the literature review, serotypes can vary in their global distribution.
Therefore, a border population, such as the one in this study, is not only exposed to binational
transit but also to a global population exposure through economic development and
transportation.
The third suggestion for future research is to broaden the span of the border region
population of study. Future research incorporating a broader span of the border region can be
beneficial in extracting additional information and details of risks for infection. Options of this
can include studying the whole border region from El Paso, Texas, to Brownsville, Texas.
Including the whole Texas border region will incorporate other forms of populations, such as
rural areas. Doing comparative studies of all border regions of the four American states and their
counterpart Mexican border states can also assist in identifying common trends and discrepancies
of the populations under study. Understanding the types of infection along these areas can greatly
assist in prevention of cases throughout the United States. As populations become more transient
and global, international characteristics of diseases are more likely to become embedded into
local populations.
The fourth suggestion for future research would be to conduct a pneumococcal vaccine
acceptance study among Texas geriatric patients along the border. With a very low vaccine rate
identified in this study additional research can help identify whether these lower vaccination
rates are due to lack of documentation, vaccine hesitancy, limited patient education on vaccine
eligibility, or limited vaccine offerings by medical providers.
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Finally, the fifth suggestion in future research is to incorporate other geocoding
techniques beyond census tracts. Utilizing geopoint data could help analyze further forms of
outcomes and assist with other information like hospital proximity and other distance-based
analysis. This includes examining and expanding to environmental factors, like access to care
(i.e., hospitals, clinics, and pharmacies).
Summary and Conclusion
A total of 333 cases were received in the dataset from Hidalgo County Health and Human
Services. Extensive data cleanup took place to categorize variables, input missing information,
and transcribe string variables into numerical or categorical values. Four duplicated patients were
identified, and their second infections were removed from the dataset, resulting in a total of 329
cases for analysis. The hypotheses in this study examined risk subgroups, hospitalization and
outcomes, and population-level characteristics for infection. Overall, the findings identified the
groups at increased risk for infection, groups with lower vaccination coverage, hospitalization
outcomes, and spatial findings for invasive pneumococcal disease. At the population level,
median household income and population density are two variables of interest, where future
research can examine these potential risk factors further. With these findings, the need for
research does not end here. Future areas for research has been established, targeting concerns and
needs to help serve the population and support the prevention of disease.
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